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ABSTRACT 
 
Jon Alan Hagar: Cytosolic LPS activates caspase-11: Implications for innate immunity and 
management of septic shock 
(Under the direction of Edward A. Miao) 
 
 
Caspases are either apoptotic or inflammatory. Amongst inflammatory caspases, caspase-
1 and -11 trigger pyroptosis, a form of programmed cell death. Whereas both can be detrimental 
in inflammatory disease, only caspase-1 has an established protective role during infection. In 
Chapter 2, we report that caspase-11 is required for innate immunity to cytosolic, but not 
vacuolar, Gram-negative bacteria. Burkholderia species that naturally invade the cytosol 
triggered caspase-11, as did cytosol invading mutants of the normally vacuolar pathogens 
Salmonella typhimurium and Legionella pneumophila. This pathway protected mice from lethal 
challenge with B. thailandensis and B. pseudomallei. Thus, caspase-11 is critical for surviving 
exposure to ubiquitous environmental pathogens. 
During endotoxemia, excessive caspase-11 activation causes shock. In Chapter 3, we 
report that contamination of the cytoplasm by lipopolysaccharide (LPS) is the signal that triggers 
caspase-11 activation in mice. Priming the caspase-11 pathway in vivo resulted in extreme 
sensitivity to subsequent LPS challenge in both wild type and Tlr4-deficient mice, whereas 
caspase 11-deficient mice were relatively resistant. Together, our data reveal a new pathway for 
detecting cytoplasmic LPS. 
Critically ill patients typically present with hyperglycemia as a result of stress hormone 
and inflammatory cytokine signaling, which induces peripheral insulin resistance over time. 
iv 
Treating hyperglycemia with insulin improves the survival of patients in intensive care units 
(ICU); however, extreme controversy has surrounded how stringently blood glucose should be 
controlled. Amongst subgroups of ICU patients, those with sepsis are particularly prone to 
hypoglycemia during insulin therapy, which is a risk factor for death. Why sepsis predisposes to 
hypoglycemia remains unknown. In Chapter 4, we show that co-delivery of insulin with 
otherwise sublethal doses of LPS induced lethal hypoglycemic shock in mice within 1-2 hours. 
LPS impaired clearance of insulin, which amplified insulin receptor and AKT signaling. Our 
results raise the possibility that septic patients have impaired insulin clearance, which could 
increase their susceptibility to hypoglycemia during insulin therapy.  Factoring differential 
insulin clearance into insulin administration protocols could minimize the risk of hypoglycemia, 
allowing safer study of whether intensive glucose control confers a survival benefit relative to 
conventional glucose control.
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CHAPTER 1: INTRODUCTION 
 
 Caspase-11 is a member of the inflammatory caspase family, which includes caspase-1, 
caspase-12, and the human caspase-11 orthologues caspase-4 and -5(1). Caspases are cysteine-
dependent proteases that recognize various conserved aspartate residues in substrate proteins(2). 
These enzymes are involved in a number of processes, but are perhaps most well known for their 
roles in programmed cell death and immunity.  
 Caspase-11 was discovered during a screen of mouse complementary DNA for caspase-1 
homologs(3), where it was found to mediate the lethality of endotoxic shock in mice
1
. While 
caspase-1 and caspase-11 both have well established roles in inflammatory diseases, only 
caspase-1 had been shown to protect against certain lethal infections. When we began the work 
described herein, we were investigating a novel caspase-1 activation pathway triggered by the 
cytosol-invasive bacterium Burkholderia thailandensis that was critical for mice to resist lethal 
infection; i.e. mice deficient in all known caspase-1 activators resisted lethal B. thailandensis 
infection, whereas mice deficient in Casp1 itself uniformly succumbed to infection. Shortly 
thereafter, Dr. Vishva Dixit’s laboratory made the key observations that all Casp1-deficient mice 
carry an inactivating passenger mutation in the adjacent Casp11 gene, and that this mutation 
accounted for several phenotypes previously ascribed to caspase-1 deficiency(4). Hypothesizing 
that caspase-11 might be involved in murine resistance to B. thailandensis, our story soon 
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 Caspase-11 exhibits 60% and 55% identity with its human orthologues caspase-4 and -5, 
respectively, and 44% identity with human and mouse caspase-1. 
2 
evolved into the first description of caspase-11 protecting a host from lethal infection, described 
in Chapter 2. Subsequent work identified lipopolysaccharide (LPS) as the bacterial ligand to 
which caspase-11 responds, a story described in Chapter 3. Finally, we serendipitously 
discovered that LPS signaling via caspase-11 and the other cellular LPS sensor, TLR4, can 
inhibit clearance of exogenous insulin, which models insulin therapy administered during sepsis 
treatment; this work is described in Chapter 4.  
 In the next section of this chapter, we review inflammatory caspase interaction with 
cytosol invasive bacteria, which is a unifying theme of this dissertation. This review describes 
the state of the field before and shortly after we published the work described in Chapters 2 and 
3, as well as a more detailed description of inflammatory caspase biology.  
 
DETECTION OF CYTOSOLIC BACTERIA BY INFLAMMATORY CASPASES
2
 
Summary 
 The sanctity of the cytosolic compartment is rigorously maintained by a number of innate 
immune mechanisms. Inflammasomes detect signatures of microbial infection and trigger 
caspase-1 or caspase-11 activation, culminating in cytokine secretion and obliteration of the 
replicative niche via pyroptosis. Recent studies have examined inflammatory caspase responses 
to cytosolic bacteria, including Burkholderia, Shigella, Listeria, Francisella, and Mycobacterium 
species. For example, caspase-11 responds to LPS introduced into the cytosol after Gram-
negative bacteria escape the vacuole. Not surprisingly, bacteria antagonize these responses; for 
                                                          
2
 This chapter section contains a manuscript that previously appeared as an article in Current 
Opinion in Microbiology. This is the author's version of the work. The full citation is: Hagar, 
J.A. and Miao, E.A. Detection of cytosolic bacteria by inflammatory caspases. Review article. 
Current Opinion in Microbiology, 17, p. 61-66, 2014. 
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example, Shigella delivers OspC3 to inhibit caspase-4. These findings underscore bacterial 
coevolution with the innate immune system, which has resulted in few, but highly specialized 
cytosolic pathogens. 
 
Introduction 
The immune defenses of the extracellular environment are severe, as are those of the 
phagolysosome. The prospect of refuge from these insults therefore makes the cytosolic 
compartment a theoretically attractive refuge for potential bacterial pathogens. However, the fact 
that bona fide cytosolic bacteria can be counted on one’s fingers (see Table 1 for a summary of 
these pathogens, their cell tropisms, and their mechanisms for invading the cytosol) highlights 
the successful immune defenses employed to maintain the sterility of the cytosolic niche. A 
number of cytosolic sensors detect signatures of infection, initiating potent inflammatory 
responses and/or host cell death. The importance of inflammatory caspases in this regard is 
underscored by the extreme susceptibility of mice deficient in these enzymes to infection by 
cytosolic pathogens. Interestingly, the few cytosolic specialist pathogens are among the most 
virulent known. Herein, we discuss the role of inflammatory caspases in the innate immune 
response to cytosolic bacteria, focusing on recent advances in our understanding of how cells 
detect intruders and trigger caspase activation, and how caspases mediate containment of the 
infection.  
 
The inflammatory caspases 
 Caspases are ancient and evolutionarily conserved proteases that are integral to 
development, homeostasis, and immunity. Some caspases are involved in apoptosis, an 
4 
immunologically silent form of programmed cell death. In contrast, the inflammatory caspases, 
caspase-11 (or the presumed human homologs caspase-4 and caspase-5) and caspase-1, initiate a 
form of lytic cell death termed pyroptosis following their activation, which releases 
inflammatory mediators, removes the replicative niche of cytosolic bacteria, and exposes 
intruders to extracellular defenses and neutrophils(5) (reviewed in (6)). In addition, caspase-1 
mediates the maturation and secretion of pro-IL-1β and pro-IL-18, two pleiotropic inflammatory 
cytokines best known for inducing fever and interferon (IFN)-γ secretion, respectively(2). 
 
The inflammasomes 
 The inflammatory caspases are expressed as inactive zymogens
3
. The canonical 
inflammasomes, a class of cytosolic pattern recognition receptors (PRR), activate caspase-1 in 
response to specific signatures of infection.  A theorized non-canonical inflammasome(s) is 
proposed to activate caspase-11(4). Relevant inflammasomes and their agonists are detailed in 
Table 2; for in-depth review, see (6) and (2). 
 
Burkholderia 
 B. pseudomallei and B. thailandensis have served as models for studying the interaction 
of inflammatory caspases and cytosolic bacteria. These Gram-negative bacteria exist 
ubiquitously in the soil of southeast Asia and sporadically elsewhere(10). Although closely 
related, only B. pseudomallei causes severe human and murine disease; however, B. 
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 The inflammatory caspases contain an N-terminal caspase recruitment and activation domain 
(CARD) that facilitates protein-protein interactions, for example with inflammasome sensors or 
the ASC adaptor protein, and large and small subdomains that confer catalytic activity(2). 
Expressed as zymogens, caspases are often cleaved into subunits that heterodimerize during 
activation; however, this is not always the case, as caspase-8(7), caspase-1(8), and caspase-11(9) 
are all capable of being activated without apparent cleavage. 
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thailandensis can infect macrophages and epithelial cells both in vitro and in vivo. B. 
pseudomallei and B. thailandensis rapidly escape the vacuole via their type III secretion system 
(T3SS) (11)(12). NLRC4 is positioned to detect signatures of T3SS activity, alerting the immune 
system to pathogens that reprogram and parasitize host cells. Not surprisingly, we and others 
found that macrophage infection triggers NLRC4 activation (13)(14). Mediating this activation, 
we showed that the T3SS rod protein BsaK is detected through NLRC4(15), and Zhao and 
colleagues demonstrated that NAIP2 is the sensor upstream of NLRC4(16).  Later the T3SS 
needle protein BsaL, as well as needle proteins from a variety of other bacteria, was found to be 
detected by murine NAIP1 and human NAIP, both signaling through NLRC4 
downstream(16)(17)(18). By an ill-defined mechanism, Burkholderia species also activate 
NLRP3(13)(14). Together, NLRC4 and NLRP3 are critical for mice to resist intranasal B. 
pseudomallei challenge(13). In this model, IL-18 is central to this resistance, coordinating 
bacterial clearance, whereas IL-1β secretion mediates immune pathology driven by neutrophil 
recruitment. 
 Recently, we determined that caspase-11 is critical for mice to resist infection by both 
virulent B. pseudomallei as well as avirulent B. thailandensis(14) (see Chapter 2). Caspase-11 
functions independently of all known inflammasomes, instead working in parallel with caspase-1 
to mediate protection against ubiquitous environmental bacteria. We discovered that caspase-11 
responds specifically to Gram-negative cytosolic bacteria, where normally vacuolar bacteria such 
as Legionella pneumophila and Salmonella enterica serovar typhimurium (S. typhimurium) 
rapidly induce caspase-11 dependent pyroptosis only after aberrant translocation to the cytosol. 
In complementary studies, we and Kayagaki and colleagues determined that cytoplasmic 
translocation of penta- and hexa-acylated LPS, but not tetra-acylated LPS, triggers caspase-11 
6 
activation(19)(9). Although enhanced by TLR4 signaling, this pathway can proceed 
independently of extracellular LPS signaling. Thus, Tlr4
–/–
 mice primed with a TLR3 agonist 
succumb to secondary LPS challenge in a model of endotoxic shock. Previous studies indicate 
that during prolonged infections, caspase-11 activates in response to all Gram-negative 
bacteria[4](20)(21)(22). We speculate that such activation may reflect vacuole leakage events 
that accumulate over 16h, which may have relevance in the setting of Gram-negative septic 
shock. In contrast, caspase-11 rapidly responds to L. pneumophila infection in pre-activated 
macrophages(23)(24); whether vacuolar integrity is compromised under these conditions remains 
to be examined. The physiologic role of caspase-11 during infection is to combat cytosolic 
bacteria.  The upstream sensor that detects cytosolic LPS remains unknown. 
 
Shigella 
 Members of the Gram-negative Shigella genus are exquisitely adapted to cause human 
gastrointestinal disease. S. flexneri infects a variety of cell types, such as intestinal epithelial cells 
and macrophages. Following phagocytosis by macrophages or T3SS-mediated uptake by 
epithelial cells, S. flexneri rapidly escapes the phagosome. In vitro, S. flexneri is robustly 
detected by caspase-1 via NLRC4(25) and, under some conditions, NLRP3(26). As an aflagellate 
bacterium, S. flexneri does not expressed flagellin.  We showed that the MxiI rod protein is 
detected via NLRC4(15), and Zhao showed this was via NAIP2(16). The S. flexneri needle 
component MxiH is also detected by murine NAIP1 and human NAIP (17). As with 
Burkholderia, NLRC4 is positioned to detect Shigella before cytosolic invasion, and thus does 
not differentiate it from vacuolar T3SS utilizing bacteria such as S. typhimurium. Whether 
inflammasome pathways more tailored to detecting cytosolic bacteria (AIM2 or caspase-11) 
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function in resistance to Shigella infection remains to be determined; however, we have found 
that both S. flexneri infection and transfection of S. flexneri lysates into macrophages activate 
caspase-11 in vitro (our unpublished observations), indicating that S. flexneri lipid A can be 
detected by the caspase-11 pathway. 
 Recently, work employing a Guinea pig model of Shigella infection, which more 
faithfully models human infection than mouse models, has implicated caspase-4 in host 
resistance to S. flexneri(27). Kobayashi and colleagues found that caspase-4 mediates epithelial 
cell death in response to several enteric pathogens, and that S. flexneri secretes an inhibitor of 
caspase-4 activation, OspC3, to counteract this innate immune response in vitro and in vivo. 
Remarkably, the authors found that OspC3 is specific in antagonizing caspase-4 and does not 
associate with caspase-11, highlighting the specificity of Shigella species for infecting humans. 
Future research will determine whether caspase-4 responds to cytoplasmic LPS as does caspase-
11, which would situate caspase-4 as a key preserver of cytosolic sterility. 
 
Francisella 
 The causative agent of tularemia, Gram-negative F. tularensis is among the most 
infectious and virulent pathogens; thus, it is classified as a category A bioweapon. F. tularensis 
infects a variety of cell types, with macrophages and neutrophils representing the primary 
replicative niches during pneumonic infection(28). F. novicida is closely related to F. tularensis, 
but is far less virulent. F. novicida lyses in the cytosol of murine macrophages, releasing DNA 
that triggers AIM2/ASC/caspase-1 (29)(30)(31)(32)(33)(34). In vivo, Aim2-deficient mice have 
increased susceptibility to F. novicida infection(31)(32). In some experimental systems, F. 
novicida also triggers NLRP3 activation(35).  However, murine infection by F. tularensis, unlike 
8 
by F. novicida, results in little detectable caspase-1 activation(36), suggesting  virulent strains 
have evolved to evade AIM2. A better understanding of this difference may have implications 
for both the treatment of and vaccination against tularemia.  
Francisella species express tetra-acylated LPS. Not surprisingly, we have found that 
macrophages do not activate caspase-11 after infection by F. novicida(9). However, transfection 
of penta-acylated lipid A from an lpxF mutant, but not wild-type tetra-acylated lipid A, triggers 
caspase-11 dependent pyroptosis. Therefore, Francisella species appear to have evolved to evade 
a major host cytosol surveillance pathway, the non-canonical inflammasome. 
 
Listeria 
 Listeria monocytogenes is a Gram-positive saprophyte and facultative pathogen that 
causes self-limited gastroenteritis in immunocompetent individuals. Of particular concern for the 
immunocompromised, L. monocytogenes infections can progress to cause sepsis, encephalitis, 
and death; in pregnant mothers, it can trigger abortion. L. monocytogenes readily escapes into the 
cytosol of epithelial cells and macrophages using the pore-forming toxin listeriolysin O (LLO). 
In vitro, macrophages detect cytosolic L. monocytogenes via NLRC4 and AIM2; NLRP3 
also detects infection under certain experimental conditions(30)(37)(38)(39)(40)(41)(42), but not 
others(43)(44). In the absence of infection, the pore-forming activity of purified LLO protein is 
sufficient to trigger NLRP3 activation(37). NLRC4 responds to flagellin sloughed from L. 
monocytogenes in the cytosol. In this case, NLRC4 acts as a specific sensor of cytosolic 
invasion, whereas it does not differentiate between cytosolic or vacuolar T3SS-expressing 
bacteria. AIM2 responds to DNA released into the cytosol following infrequent lysis of L. 
monocytogenes.  
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In vivo, Casp1
–/–
 Casp11
–/–
 mice may have increased susceptibility to L. monocytogenes 
infection (45); however, this was not replicated in another publication(44). Furthermore, the 
contributions of individual inflammasomes during in vivo infection are not defined. 
Nevertheless, L. monocytogenes appears to have evolved to limit inflammasome detection: LLO 
activity is optimal in the acidic environment of the phagosome, thus limiting its potential to 
trigger NLRP3; flagellin expression is repressed during growth at host temperature; and few 
bacteria lyse in the cytosol, thus limiting cytosolic DNA exposure. The efficiency of these 
evasive strategies is demonstrated by the rapid clearance of L. monocytogenes forced to express 
flagellin in vivo(44)(46). 
By virtue of its nature as a Gram-positive bacterium, L. monocytogenes does not contain 
LPS, and thus is not detected by caspase-11(9)(47).   
 
Rickettsia 
 Members of the genus Rickettsia are Gram-negative, obligate intracellular pathogens that 
invade the cytosol of vascular endothelial cells and macrophages, causing a variety of arthropod-
borne diseases. Little research to date has investigated the interactions of inflammatory caspases 
and Rickettsia; however, infected mouse peritoneal macrophages secrete IL-1β(48), suggesting 
that caspase-1 responds to certain Rickettsia species. Interestingly, IFN-γ primed RAW264.7 
macrophage-like cells undergo rapid cell death (within 4h) following infection with R. 
prowazekii(49). It is tempting to speculate that the enhanced bactericidal activity of IFN-γ 
primed macrophages potentiates AIM2 or caspase-11 detection of Rickettsia. 
 
10 
Mycobacterium 
 Among Mycobacterium species, M. marinum is distinct in that it rapidly escapes the 
phagosome to replicate in the cytosol and spread cell-to-cell. Vacuolar escape requires ESAT-6, 
a secretion product of the ESX-1 type VII secretion system suggested to have membrane pore 
forming activity(50). Although M. tuberculosis is traditionally considered a vacuolar pathogen of 
macrophages, recent studies suggest it may exist in the cytosol for at least part of its intracellular 
life cycle (reviewed in (51)). 
 A number of studies have investigated the role of inflammatory caspases in immunity to 
M. tuberculosis and M. marinum. While the in vivo importance of IL-1 and IL-1 are well 
accepted, the role of NLRP3, ASC, and caspase-1 remain controversial both in vivo and in vitro 
(for a more in-depth review, see (2)). Herein we limit our discussion to the recent studies 
examining caspase-1 activation in response to cytosolic bacterial exposure. Several studies 
implicate ESX-1 and ESAT-6 in caspase-1 activation(52)(53)(54)(55)(56)(57). Abdallah and 
colleagues suggest that ESX-1 translocation of mycobacteria to the cytosol potentiates 
subsequent ESX-5 dependent inflammasome activation(58). M. tuberculosis DNA can access the 
cytosol in a manner dependent on ESX-1, where it triggers STING-dependent type I interferon 
production(59). DNA from M. tuberculosis and M. bovis also trigger AIM2/ASC/caspase-
1(60)(61), and Aim2
–/–
 mice appear susceptible to M. tuberculosis infection, suggesting a 
physiologic relevance to the in vitro detection data(60). A recent contradictory report suggests 
that virulent M. tuberculosis strains actually inhibit AIM2 activation, whereas nonvirulent strains 
do not(62); use of different macrophage types in these studies may reconcile their conflicting 
findings. 
11 
Conclusions 
 In recent years, our understanding of inflammatory caspase activation has expanded to 
include several new sensor-stimulus pairs, such as AIM2 and DNA, NAIP1 and the T3SS needle, 
and LPS and the non-canonical inflammasome. These findings have elucidated how the 
inflammatory caspases and, more generally, the innate immune system restrict the ability of 
pathogens to establish cytosolic growth niches. At the same time, they pose a number of 
questions, such as the identity of the non-canonical inflammasome. Furthermore, several models 
of cytosolic pathogen interaction with inflammatory caspases remain under-explored, such as 
Rickettsia infection and the emerging paradigm of cytosolic M. tuberculosis. Future studies will 
begin to fill these gaps and, surely, raise a number of new questions. 
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Tables 
Genus Gram +/- Cell tropism Vacuolar escape 
determinants, 
bacterial 
    
Burkholderia - Mφ, PMN, 
epithelial cells 
T3SSBSA 
    
Shigella - Mφ, DC, 
intestinal 
epithelial cells 
Mxi-Spa T3SS, 
IpaB 
    
Francisella - Mφ, PMN, DC, 
epithelial cells, 
hepatocytes 
IglC, MglA, 
FTT11103 
    
Listeria + Mφ, intestinal 
epithelial 
LLO, 
phospholipase C 
    
Rickettsia - Vascular 
endothelial, Mφ 
Phospholipases, 
hemolysin 
    
Mycobacterium Acid-fast + Mφ ESX-1 T7SS, 
ESAT-6 
    
Table 1.1. Cell tropism and vacuolar escape determinants of cytosolic bacteria. 
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Bacteria Caspase-1   Caspase-11 
or -4 
Stimulus/sensor NLRC4 NLRP3 AIM2  
Burkholderia 
 
BsaK/NAIP2 Infection  LPS/casp11 
Shigella Needle/NAIP1 
and human 
NAIP 
 
Rod/NAIP2 
Infection  LPS/casp11 
?/casp4 
Francisella  Infection 
(human) 
DNA  
Listeria 
 
Flagellin/NAIP5 Infection, LLO DNA  
Rickettsia 
 
    
Mycobacterium 
 
 Infection, 
ESAT-6 
DNA  
     
Antagonism     
Burkholderia 
 
    
Shigella 
 
   OspC3 
inhibits 
casp4 
Francisella   possible Tetra-acyl 
LPS 
Listeria Represses 
flagellin at host 
temperatures 
pH dependent 
LLO activity 
  
Rickettsia 
 
    
Mycobacterium  Zmp1 
metalloprotease 
  
     
Table 1.2. Interaction of inflammatory caspases and cytosolic bacteria. 
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CHAPTER 2: CASPASE-11 PROTECTS AGAINST BACTERIA THAT ESCAPE THE 
VACUOLE
4
 
 
SUMMARY 
Caspases are either apoptotic or inflammatory. Amongst inflammatory caspases, caspase-
1 and -11 trigger pyroptosis, a form of programmed cell death. Whereas both can be detrimental 
in inflammatory disease, only caspase-1 has an established protective role during infection. Here, 
we report that caspase-11 is required for innate immunity to cytosolic, but not vacuolar, bacteria. 
Although Salmonella typhimurium and Legionella pneumophila normally reside in the vacuole, 
specific mutants (sifA and sdhA, respectively) aberrantly enter the cytosol.  These mutants 
triggered caspase-11, which enhanced clearance of S. typhimurium sifA in vivo. This response 
did not require NLRP3, NLRC4, or ASC inflammasome pathways. Burkholderia species that 
naturally invade the cytosol also triggered caspase-11, which protected mice from lethal 
                                                          
4
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manuscript with Dr. Aachoui and Dr. Miao. This is the author's version of the work. It is posted 
here by permission of the AAAS for personal use, not for redistribution. The definitive version 
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Vance, R.E., Aderem, A., and Miao, E.A. Caspase-11 protects against bacteria that escape the 
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challenge with B. thailandensis and B. pseudomallei. Thus, caspase-11 is critical for surviving 
exposure to ubiquitous environmental pathogens. 
 
CASPASE-11 PROTECTS AGAINST BACTERIA THAT ESCAPE THE VACUOLE 
Canonical inflammasomes, such as NLRP3, NLRC4, and AIM2, are cytosolic sensors 
that detect pathogens or danger signals and activate caspase-1, leading to secretion of the 
proinflammatory cytokines interleukin (IL)-1β and IL-18, and pyroptosis, a form of programmed 
cell death (1). Pyrin domain-containing inflammasomes, including NLRP3, signal through the 
ASC adaptor protein to recruit caspase-1 (Fig. 2.1). Many diverse agonists cause cytosolic 
perturbations that are detected through NLRP3; however the underlying mechanisms remain 
obscure (2). In contrast, the CARD domain-containing inflammasome NLRC4 can signal 
directly to caspase-1 resulting in pyroptosis, as well as indirectly through ASC to promote IL-1β 
and IL-18 secretion (Fig. 2.1) (1, 3). NLRC4 detects bacterial flagellin and type III secretion 
system (T3SS) rod or needle components within the macrophage cytosol (4–6). Together, 
NLRC4 and the ASC dependent inflammasomes account for all known canonical caspase-1 
activation pathways. 
Burkholderia pseudomallei is a Gram-negative bacterium endemic to Southeast Asia that 
causes mellioidosis and is a potential biologic weapon (7). B. pseudomallei uses a T3SS to 
escape the phagosome and replicate in the cytosol. NLRC4 and NLRP3 both detect B. 
pseudomallei, promoting IL-1β secretion from murine bone marrow-derived macrophages 
(BMM) ((8) and Fig. 2.2A). Despite encoding many of the same virulence factors as B. 
pseudomallei, including T3SS and T6SS, the closely related B. thailandensis is far less virulent 
(9). We therefore hypothesized that NLPR3 and NLRC4 also detect B. thailandensis, and indeed, 
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NLRP3 and NLRC4 accounted for all IL-1β secretion in response to B. thailandensis (Fig. 2.2B). 
We next determined whether inflammasome activation is critical to survival following B. 
thailandensis challenge using caspase-1 deficient mice. Kayagaki et al. recently showed that all 
existing caspase-1 deficient mice also lack caspase-11 due to the backcrossing of a mutant 
Casp11 allele from 129 into C57BL/6 mice (10). Inflammasome detection was critical for 
resistance to B. thailandensis, as Casp1
–/–
Casp11
–/–
 animals succumbed to the infection (Fig. 
2.2C and Fig. 2.3A). In contrast, wild type C57BL/6 mice survived high dose intraperitoneal or 
intranasal challenge (Fig. 2.2C and Fig. 2.3A). Surprisingly, Nlrc4
–/–
Asc
–/–
 mice that are deficient 
in all known canonical inflammasomes were also resistant (Fig. 2.2D and Fig. 2.3B). This 
indicated that an unknown signaling pathway provides protection via either caspase-1 or -11 (see 
pathway schematic Fig. 2.1). Resistance to B. thailandensis was at least partially independent of 
IL-1β and IL-18, depending on the route of infection (Fig. 2.2E and Fig. 2.3C), suggesting that 
both cytokines and pyroptosis can contribute to protection. We therefore examined pyroptosis in 
vitro, and found that cytotoxicity in response B. thailandensis was impaired in Casp1
–/–
Casp11
–/–
 
BMM (Fig. 2.2F). Consistent with our in vivo data, pyroptosis in vitro did not require Nlrc4 or 
Asc (Fig. 2.2F). B. pseudomallei similarly triggered pyroptosis in Nlrc4
–/–
Asc
–/–
 macrophages 
(Fig. 2.2G). These results indicate that a pyroptosis-inducing pathway distinct from all known 
canonical inflammasomes detects B. thailandensis and protects against lethal infection. 
Inflammasomes discriminate pathogens from non-pathogens by detecting contamination 
or perturbation of the cytosolic compartment (11). The B. thailandensis T3SS facilitates bacterial 
access to the cytosol, and was required for induction of pyroptosis, whereas the virulence-
associated T6SS was dispensable (Fig. 2.4A). We therefore hypothesized that macrophages 
detect vacuolar lysis or release of bacteria into the cytosol. 
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In order to establish their intracellular vacuolar growth niche, Salmonella typhimurium 
and Legionella pneumophila use T3SS and T4SS, respectively, to translocate effector proteins 
that work in concert to maintain the stability of these altered bacteria-containing vacuoles (12–
14). Loss of the S. typhimurium SifA or L. pneumophila SdhA effectors causes rupture of the 
vacuole and release of bacteria into the cytosol (15–17). S. typhimurium uses two distinct T3SS 
encoded by the Salmonella pathogenicity island 1 (SPI1) and SPI2; these two T3SS translocate 
distinct batteries of effectors, such as SifA by SPI2 (18). While S. typhimurium-expressing SPI1 
and flagellin are readily detected by NLRC4 (19, 20), bacteria grown under conditions that 
mimic the vacuolar environment express SPI2 and repress flagellin, minimizing canonical 
inflammasome detection (1, 11, 21). Infection of BMMs with S. typhimurium that lacked sifA, 
however, significantly increased IL-1β secretion and pyroptosis (Fig. 2.4, B and C). IL-1β 
secretion was dependent on canonical inflammasomes (Fig. 2.4B), whereas pyroptosis was still 
observed in Nlrc4
–/–
Asc
–/–
 and Nlrp3
–/–
Nlrc4
–/–
 macrophages (Fig. 2.4C). Furthermore, the 
NLRC4 inflammasome agonist flagellin was not required for these responses (Fig. 2.4, D and E). 
Thus, macrophages detect S. typhimurium when it aberrantly enters the cytosol, activating 
pyroptosis independent of all known canonical inflammasomes. 
L. pneumophila also translocates flagellin through its T4SS. Thus, L. pneumophila 
mutants lacking flagellin (∆flaA) evaded NLRC4 detection (Fig. 2.4F) (2). In contrast, L. 
pneumophila ∆flaA ∆sdhA mutants induce caspase-1 activation (16, 17), IL-1β secretion (17), 
and pyroptosis (Fig. 2.4F) (17). The AIM2-ASC canonical inflammasome has been implicated in 
L. pneumophila ∆flaA ∆sdhA-induced IL-1β secretion, likely by detecting DNA released from 
bacteria lysing in the cytosol; however, the role of AIM2-ASC in pyroptosis was not examined 
(17). Analogous to S. typhimurium ∆sifA, L. pneumophila ∆flaA ∆sdhA induced pyroptosis in the 
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absence of flagellin and ASC (Fig. 2.4G), ruling out all canonical inflammasomes in triggering 
pyroptosis under these infection conditions. These data demonstrate that diverse bacteria are 
detected in the cytosol. 
Because IL-1β secretion required the canonical inflammasomes whereas pyroptosis did 
not, we hypothesized that cell death is triggered by a distinct mechanism mediated by caspase-
11. Like caspase-1, caspase-11 is an inflammatory caspase that can directly trigger pyroptosis 
(Fig. 2.1). Caspase-11 can also promote IL-1β secretion dependent upon NLRP3, ASC, and 
caspase-1 (10, 22–24). Because caspase-1 is activated by recruitment to an oligomerized 
platform known as the inflammasome, Kayagaki et al. hypothesized that a similar oligomeric 
structure would activate caspase-11, which they termed the non-canonical inflammasome (10). 
Although the cholera toxin B subunit and many different Gram-negative bacteria can trigger 
caspase-11 activation in vitro (10, 22–24), the nature of the physiologic stimulus that activates 
caspase-11 during infection remains uncertain. 
Caspase-11 activation requires priming through a Toll like receptor 4 (TLR4)-TRIF-
STAT1 pathway (10, 22–24). Consistent with this, Tlr4–/– and Trif–/– macrophages did not 
undergo pyroptosis after S. typhimurium ∆sifA infection, whereas cell death was observed in 
macrophages deficient in the other TLR4 adaptor, Myd88 (Fig. 2.5A). This dependence could be 
overcome by priming the macrophages with interferon (IFN)-γ (Fig. 2.5A), which signals 
through STAT1. Interestingly, IFN-γ or LPS priming significantly increased the sensitivity of 
macrophages to S. typhimurium ∆sifA (Fig. 2.5A and  Fig. 2.6A). These priming effects 
correlated with increased caspase-11 expression (Fig. 2.6, B and C), but could also be mediated 
by enhancing aberrant vacuolar rupture. We used retroviruses to complement Casp1
–/–
Casp11
–/–
 
macrophages with either Casp1 or Casp11 in order to determine which was involved. Caspase-
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11 alone promoted pyroptosis without IL-1β secretion after B. thailandensis infection, whereas 
caspase-1 enabled both responses (Fig. 2.5B). This is consistent with B. thailandensis detection 
through NLRC4 and/or NLRP3 activating caspase-1 (8) and an additional pathway activating 
caspase-11. In contrast, the responses to S. typhimurium ∆sifA or L. pneumophila ∆flaA ∆sdhA 
acted through caspase-11, and not caspase-1 (Fig. 2.5, C and D). We further confirmed that 
caspase-11 was responsible for the cell death observed in Nlrc4
–/–
Asc
–/–
 macrophages using short 
hairpin (sh)RNAmir (Fig. 2.5, E and F, and Fig. 2.6E). Finally, Casp11
–/–
 BMM revealed that 
caspase-11 was required for pyroptosis after B. thailandensis, S. typhimurium ∆sifA, and L. 
pneumophila ∆flaA ∆sdhA (Fig. 2.5, G to I). Although a previous report suggested that NLRC4 
signals through caspase-11 to alter phagosomal trafficking (25), we saw no evidence that NLRC4 
contributes to caspase-11 dependent cell death (Fig. 2.2F, Fig. 2.4D, and Fig. 2.7). Pyroptosis 
initiated by caspase-11 was morphologically similar to pyroptosis triggered by caspase-1 (Fig. 
2.8, A and B). Therefore, macrophages activate caspase-11 in response to cytosolic B. 
thailandensis, S. typhimurium, or L. pneumophila (Fig. 2.1). 
S. typhimurium ∆sifA is attenuated (15), attributed to the role of SifA in coordinating 
intracellular trafficking of the Salmonella-containing vacuole. We hypothesized that this 
attenuation was actually due to innate immune detection though caspase-11. Indeed, S. 
typhimurium ∆sifA was mildly attenuated in C57BL/6 mice as expected, but this was not 
replicated in Casp1
–/–
Casp11
–/–
 mice (Fig. 2.9, A and B). We next determined the relative 
clearance of S. typhimurium ∆sifA during co-infection with wild type S. typhimurium, a more 
quantitative measure of virulence than lethal challenge. We recovered 16 times more wild type S. 
typhimurium than S. typhimurium ∆sifA from C57BL/6 mice; however, in Casp11–/– mice we 
only recovered 4 times as many wild type bacteria (Fig. 2.9C).  This indicates that caspase-11 
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clears S. typhimurium ∆sifA in vivo; in contrast, wild type S. typhimurium effectively evades 
caspase-11 (23) by remaining within the vacuole. The remaining S. typhimurium ∆sifA 
attenuation likely reflects the role of sifA as a virulence factor promoting intracellular replication. 
Moreover, all known canonical inflammasomes were dispensable for S. typhimurium ∆sifA 
clearance, as were IL-1β and IL-18 (Fig. 2.9D), implicating pyroptosis as the mechanism of 
clearance. Clearance of bacteria after pyroptosis is mediated by neutrophils through generation 
of reactive oxygen (21). Consistent with this, NADPH oxidase deficient p47phox
–/–
 mice were 
also defective for clearance of S. typhimurium ∆sifA (Fig. 2.9D). Interestingly, TLR4 and IFN-γ 
were not required (Fig. 2.9E), suggesting that there is redundant priming of caspase-11 pathways 
in vivo. Therefore, caspase-11 protects mice from S. typhimurium ∆sifA, and because IL-1β and 
IL-18 are not required, pyroptosis is likely to be the mechanism of bacterial clearance in this 
case. 
We next examined the susceptibility of Casp11
–/–
 mice to the naturally cytosolic 
pathogens B. thailandensis and B. pseudomallei. While C57BL/6 mice are resistant to B. 
thailandensis infection, Casp11
–/–
 mice succumbed (Fig. 2.9F). Likewise, Casp11
–/–
 succumbed 
to B. pseudomallei infection, whereas C57BL/6 mice survived (Fig. 2.9G). Since Nlrc4
–/–
 mice 
are also susceptible to B. pseudomallei infection (8), we conclude that both caspase-1 and 
caspase-11 play critical roles in limiting B. pseudomallei infection. 
Collectively, these data demonstrate, for the first time, that caspase-11 protects animals 
from lethal infection by bacteria that have the ability to invade the cytosol. This could be critical 
for defense against ubiquitous environmental bacteria such as B. thailandensis that encode 
virulence factors, but have not evolved to evade caspase-11 detection. It will be interesting to 
determine whether caspase-11 is activated in response to the process of vacuolar rupture or the 
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presence of bacteria within the cytosol. Caspase-11 also responds to vacuolar bacteria under 
delayed kinetics, but such responses have not been shown to provide protection from infection in 
vivo (10, 22–24). LPS-induced septic shock is mediated by caspase-11 (10), suggesting that 
caspase-11 can be activated by other mechanisms besides cytosol-localized bacteria. Thus, we 
propose that caspase-11 provides protection against pathogens, but is dysregulated during 
overwhelming infection, contributing to septic shock and mortality. It will be interesting to 
determine if caspase-11 triggers eicosanoid secretion as is seen for caspase-1, and whether these 
mediators contribute to septic shock (26). The identity of the hypothesized non-canonical 
inflammasome(s) that activate caspase-11 and the precise nature of the activating signal will 
shed more light on the mechanisms by which caspase-11 can both promote innate immunity and 
exacerbate immunopathology. These insights may lead to novel therapies to treat infection and 
sepsis. 
 
MATERIALS AND METHODS 
Mice and in vivo infections.  
Wild-type C57BL/6 (Jackson Laboratory), Asc
–/–
(27), Nlrp3
−/−
 (28), Nlrc4
−/−
 (27), Nlrp3
–
/–
Nlrc4
–/–
, Nlrc4
–/–
Asc
–/–
,  Il1b
–/–
Il18
–/–
 (29, 30), Casp1
–/–
Casp11
129mt/129mt
 referred to as Casp1
–/–
Casp11
–/–
 (31), Casp11
−/−
 (10), Ifng
−/−
 (Jackson # 002287) (32), Tlr4
lps-del/lps-del
 referred to as 
Tlr4
–/–
 (Jackson # 007227), Trif 
Lps2/Lps2
 referred to as Trif
–/–
 (Jackson # 005037), Myd88
−/−
 
(Jackson # 009088), and Ncf1
m1J/m1J
 referred to as p47phox
–/–
 (Jackson # 004742) (33) mice were 
used in this study.  Mice were housed in a specific pathogen–free facility. All protocols were 
approved by the Institutional Animal Care and Use Committee at the University of North 
Carolina at Chapel Hill, the Institute for Systems Biology, Seattle Biomedical Research Institute, 
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or The University of California at Berkeley and met guidelines of the US National Institutes of 
Health for the humane care of animals. 
For study of lethal B. thailandensis challenge, mice were infected via intraperitoneal (i.p.) 
injection with 2 × 10
7
 cfu (except Fig. 2.2D at 2 x 10
6
 cfu) or intranasal (i.n.) inoculation with 
1x10
4
 cfu. For Figure 4F, mice were infected with 2 x 10
7
 cfu i.p. of B. thailandensis that was 
passaged through as Casp1
–/–
Casp11
–/–
 mouse (strain E264-1); this strain displays more 
synchronized infection kinetics than the parental E264.  For B. pseudomallei infection studies, 
mice were infected with 100 cfu i.n.  For monotypic S. typhimurium and S. typhimurium ∆sifA 
challenges, C57BL/6 mice were infected via i.p. injection with 1000 cfu.  Because Casp1
–/–
Casp11
–/–
 mice have a mild innate susceptibility to S. typhimurium infection, a lower dose of 250 
cfu was used, which yielded more comparable infection kinetics in comparison to C57BL/6 
mice. For numbers of mice used in lethal challenges see Table S3.  For studies of coinfection 
with S. typhimurium and S. typhimurium ∆sifA, 4 or 5 mice were infected with 5x104 cfu each of 
S. typhimurium pWSK29 (ampicillin resistant) and S. typhimurium ∆sifA pWSK129 (kanamycin 
resistant). Spleens were harvested 2 days post infection and homogenized in sterile PBS. Viable 
cfu in homogenates were enumerated by plating serial dilutions on agar containing ampicillin 
(100μg/mL) or kanamycin (40μg/mL). Bacterial competitive indices were calculated as the log 
of (S. typhimurium ∆sifA cfu / S. typhimurium cfu). 
 
Bacterial growth conditions 
Burkholderia strains were grown in Luria-Bertani medium (LB) overnight at 37°C. For in 
vitro infections, bacteria were pelleted from 1mL of culture were opsonized with 50μL of mouse 
sera for 30 min at 37°C and then suspended in 1 ml of DMEM.  Salmonella strains were grown 
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in LB overnight at 37°C. For induction of SPI2 expression, bacteria were cultured as previously 
described (34). Briefly, freshly streaked bacterial colonies were used to inoculate LB. After 16-
20h growth at 37°C, bacteria were pelleted, washed with PBS 3X, and then back-diluted to an 
OD600 of 0.026 in SPI2 media and grown 16-18h at 37°C.  SPI2 media: 0.1% w/v casamino 
acids, 38mM glycerol, 5mM KCl, 7.5mM (NH4)2SO4, 0.5mM K2SO4, 1mM KH2PO4, 100mM 
Tris, 100mM BisTris, 200uM MgCl2, 100mM Hepes; pH to 6.5. Legionella strains were grown 
overnight at 37°C in buffered yeast extract supplemented with FeNO3, thymidine, and cysteine 
(35). 
 
Macrophage culture, infection, and analysis of inflammasome activation  
BMMs were prepared as described (20). For infections, macrophages were seeded into 
96-well tissue culture treated plates at a density of 5x10
4
 cells/well (B. thailandensis, B. 
pseudomallei, S. typhimurium) or 1x10
5
 cells/well (L. pneumophila). When indicated, 
macrophages were primed with lipopolysaccharide (50 ng/ml) or IFN-γ (8 ng/ml ) overnight. 
Bacteria were added to BMMs at MOI 50 (B. thailandensis, B. pseudomallei, S. typhimurium) or 
MOI 1 (L. pneumophila), centrifuged for 5 min at 200 xg (B. thailandensis, B. pseudomallei, S. 
typhimurium) or 10 min at 400 xg (L. pneumophila), and then incubated at 37°C for 1hr. After 1 
hour extracellular bacterial growth was stopped by addition of 15 μg/ml gentamicin (S. 
typhimurium) or 300 μg/ml kanamycin (B. thailandensis). Supernatant samples were collected at 
the indicated time points. Cytotoxicity was defined as the percentage of total lactate 
dehydrogenase released into the supernatant and was determined as described (36) or using the 
CytoTox 96 assay kit (Promega). IL-1β secretion was determined by enzyme-linked 
immunosorbent assay (ELISA) (R&D Systems). 
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Complementation and knockdown of Casp1 and Casp11 
Bone marrow derived macrophages were immortalized (iBMM) as described (37). For 
complementation of Casp1 and Casp11 in Casp1
–/–
Casp11
–/–
 iBMMs, macrophages were 
transduced with pMXsIP (38) derived retrovirus carrying Casp1 or Casp11; for complementation 
of primary BMMs, macrophages were transduced with MSCV derived retroviruses (39). For 
knockdown of Casp11 expression in immortalized Nlrc4
–/–
Asc
–/–
 iBMMs, macrophages were 
transduced with LMP retrovirus carrying shRNAmir seed sequences targeting Casp11 transcripts 
or scrambled control sequence (Open Biosystems, UNC Lenti-shRNA Core Facility). 
 
Caspase-11 mRNA and protein expression 
Total RNA was extracted using TRIzol solution (Invitrogen) and overall RNA quality 
was analyzed with an Agilent 2100 Bioanalyzer. Sample mRNA was amplified, labeled and 
hybridized to GeneChip Mouse Genome 430 2.0 arrays according to the array manufacturer’s 
instructions (Affymetrix). Probe intensities were measured and then processed with Affymetrix 
GeneChip operating software into image analysis (.CEL) files. The Affymetrix CEL files were 
normalized with robust multi-array average expression measure (40) and baseline scaling using 
the software Bioconductor (41).  Plotted are average log2 normalized expression intensities, 
computed from 2-3 biological replicates/condition. 
Caspase-11 protein expression in macrophages was determined after incubation with LPS 
(50ng/mL) or IFN-γ (8ng/mL) overnight. Protein from 1x105 cells was analyzed by Western blot 
using anti-caspase-11 antibody (17D9, Novus) diluted 1:500. Blots were stripped and equivalent 
loading of protein was ensured by Western blot using anti-β-actin HRP antibody (Cat. # 20272, 
AbCam) diluted 1:20,000. 
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Fluorescence Microscopy 
Nlrc4
–/–
Asc
–/–
 and Casp11
–/–
 BMMs were seeded onto glass cover slips in 24-well plates 
at a density of 2.78x10
5
 cells/well. Macrophage were primed with IFN-γ (8 ng/ml) overnight 
then infected with S. typhimurium ∆sifA. At 8 hours post infection, cells were washed with PBS 
and then incubated for 15 min on ice with Hoechst (0.12 µg/ml) and Propidium Iodide (PI) (1 
µg/ml).  Images were acquired using an EVOS florescent microscope. 
 
Statistical analysis 
Error bars indicate the standard deviation of technical replicates. For mouse survival 
experiments, statistically significant differences between samples were determined using log 
rank (Mantel Cox). For all other experiments, statistically significant differences between 
samples were determined using a two-tailed, unpaired Student’s T-test. * = p ≤0.05, n.s. = p 
>0.05. 
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FIGURES AND TABLES 
 
 
 
 
 
 
Figure 2.1. Schematic of inflammasome detection pathways.  
Canonical inflammasomes including NLRP3, AIM2, and NLRC4 activate caspase-1. NLRC4 
contains a CARD domain that can bind to the CARD of caspase-1 directly through homotypic 
interaction, triggering pyroptosis. The NLRC4 also binds ASC through CARD homotypic 
interactions, resulting in recruitment of the entire complement of cellular ASC into a single ASC 
focus. The Pyrin domain of NLRP3 or AIM2 cannot bind directly to caspase-1, but triggers 
formation of the ASC focus via Pyrin-Pyrin homotypic interactions. The ASC focus recruits and 
activates caspase-1, resulting in its proteolytic maturation to the p10 and p20 fragments, and 
subsequent IL-1 and IL-18 cleavage and secretion. Therefore, cells that are deficient in both 
Nlrc4 and Asc cannot signal through any known canonical inflammasome. The activating 
platform for caspase-11 remains unknown; nevertheless, the hypothetical activator was named 
the non-canonical inflammasome. Our data indicate that cytosolic bacteria are detected through 
this hypothetical non-canonical inflammasome, resulting in caspase-11-dependent pyroptosis. 
Caspase-11 activation also triggers NLRP3 activation via an unknown mechanism (denoted by 
an arrow through tunnels). 
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Figure 2.2. Burkholderia detection and protection conferred by Casp1/11 is independent of 
all known canonical inflammasomes. 
Lipopolysaccharide (LPS) primed BMMs were infected with B. pseudomallei (A, G) or B. 
thailandensis (B, F) for 4h. (A and B) IL-1β secretion was determined by ELISA or (F and G) 
cytotoxicity was determined by LDH release assay. (C, D, and E) Survival curves of wild type 
C57BL/6 or the indicated knockout mice infected 2x10
7
 cfu i.p. with B. thailandensis. Data are 
representative of at least 3 (A, B, F, G) or 2 (D, E) experiments. (C) Data are pooled from 3 
experiments. For number of mice in each panel see table S2. Statistically significant differences 
with respect to controls are indicated (Student's t test or log rank test for survival; * = p ≤ 0.05, 
n.s. = p > 0.05). 
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Figure 2.3. Burkholderia protection conferred by Casp1/11 is independent of all known 
canonical inflammasomes. 
(A-C) Wild type C57BL/6 or the indicated knockout mice were infected i.n. with B. 
thailandensis and survival was monitored. Data are representative of 4 (A), 1 (B) or pooled from 
2 (C) experiments. For number of mice in each panel see Table S1.2. Statistically significant 
differences with respect to controls are indicated (log rank test for survival; * = p < 0.05). 
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Figure 2.4. Diverse cytosolic bacteria activate pyroptosis independent of NLRC4, NLRP3 
and ASC.  
(A) LPS-primed BMMs were infected for 4h with either B. thailandensis or the indicated 
mutants and cytotoxicity was determined. BMMs were infected for 8h with (B) S. typhimurium 
or S. typhimurium ∆sifA, (D) S. typhimurium ∆sifA or S. typhimurium ∆sifA flgB (D) and 
cytotoxicity was determined. LPS-primed BMM were infected for 8h with S. typhimurium or S. 
typhimurium ∆sifA (C), S. typhimurium ∆sifA or S. typhimurium ∆sifA flgB (E) and IL-1β 
secretion was determined. (F and G) Cytotoxicity in wild type or Asc
–/–
 BMMs infected for 4h 
with L. pneumophila, L. pneumophila ∆flaA or L. pneumophila ∆sdhA ∆flaA. Cytotoxicity was 
determined by LDH release and IL-1β secretion by ELISA. Data are representative of at least 3 
experiments. Statistically significant differences with respect to controls are indicated (Student's 
t test; * = p ≤ 0.05, n.s. = p > 0.05). 
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Figure 2.5. Caspase-11 mediates pyroptosis after infection by cytosolic bacteria.  
(A-I) Macrophage cytotoxicity and IL-1β secretion were determined after infection with S. 
typhimurium ΔsifA (8h), L. pneumophila ΔflaA ΔsdhA (4h), or B. thailandensis (4h). (A) 
C57BL/6, Casp1
–/–
Casp11
–/–
, Tlr4
–/–
, Trif
–/–
, and Myd88
–/–
 BMM infected with S. typhimurium 
∆sifA with or without IFN-γ priming prior to infection. (B and C) Retroviral transduction was 
used to complement Casp1 or Casp11 in Casp1
–/–
Casp11
–/–
 iBMM. Macrophages were primed 
with LPS (B) or IFN-γ (C) and responses to B. thailandensis (B) or S. typhimurium ΔsifA (C) 
infection were examined. (D) Control or complemented Casp1
–/–
Casp11
–/–
 BMM infected with 
L. pneumophila ΔflaA ΔsdhA. (E and F) Retroviral transduction was used to introduce control or 
Casp11-targeting shRNAmir into Nlrc4
–/–
Asc
–/–
 iBMM. Macrophages were primed overnight 
with LPS (E) or IFN-γ (F) and then infected as indicated. (G to I) C57BL/6, Casp1–/–Casp11–/–, 
and Casp11
–/–
 BMM infected with B. thailandensis (G), S. typhimurium ΔsifA (H), or L. 
pneumophila ΔflaA ΔsdhA (I). Data are representative of at least 3 (A-C, E, G, H) or 2 (D, F, I) 
independent experiments. Statistically significant differences with respect to controls are 
indicated (Student's t test; * = p ≤ 0.05). nd, none detected. 
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Figure 2.6. TLR ligands and IFN-γ enhance Casp11 expression and caspase-11- dependent 
cell death.  
(A) Untreated, LPS-primed, or IFN-!-primed BMMs were infected with S. typhimurium ΔsifA 
and cytotoxicity was determined. (B) Transcriptional upregulation of Casp11 in C57BL/6 BMMs 
after priming with the indicated molecules was determined using Affymetrix GeneChip 
technology. (C) Caspase-11 expression in untreated, LPS-primed, and IFN-γ-primed C57BL/6 
BMMs was determined by immunoblot. Blots were stripped and β-actin expression was 
determined as a loading control. (D) Caspase- 11 expression in untreated, LPS-primed, and IFN-
γ-primed control or Casp11 shRNAexpressing Nlrc4-Asc iBMMs was determined by 
immunoblot. Loading controls were performed as in (C). Results are representative of more than 
3 (A, B), 2 (C), or 1 (D) experiments. Statistically significant differences with respect to controls 
are indicated (Student‘s T-test; * = p < 0.05). 
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Figure 2.7. Caspase-11 is not required for pyroptosis induced by flagellin expressing wild 
type L. pneumophila.  
Wild type L. pneumophila inadvertently translocate flagellin into the macrophage cytosol, 
resulting in detection through NLRC4, which activates Caspase-1. We investigated whether this 
response was altered in the absence of Caspase-11. C57BL/6, Casp1
–/–
Casp11
–/–
, and Casp11
–/– 
BMM infected with L. pneumophila at an MOI of 1 and cytotoxicity was determined 4 hours 
later; C57BL/6 and Casp11
–/–
 BMMs showed similar cytotoxicity, indicating that Caspase-11 is 
not required for NLRC4-induced pyroptosis. Data are representative of at least 3 independent 
experiments. Statistically significant differences with respect to controls are indicated (Student’s 
T test; * = p < 0.05). 
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Figure 2.8. Morphology of S. typhimurium ΔsifA-induced pyroptosis. 
IFN-γ-primed Nlrc4–/–Asc–/– or Casp11–/– BMMs were infected for 8h with S. typhimurium ΔsifA 
(MOI 50) (A) Representative fluorescence microscopy images of BMM stained with membrane 
permeant Hoechst and membrane impermeant propidium iodide (PI) 8 hours post infection as a 
measure of cell death in addition to LDH release. Although Hoechst is a membrane permeant 
dye, its staining intensity significantly increased in pyroptotic cell due afer membrane rupture; in 
order to visualize both intact and pyroptotic cells the image is over-exposed for lysed cells, 
making their nucleus appear larger in the Hoechst channel. (B) Caspase-1-dependent pyroptotic 
cell death is known to be inhibited by addition of glycine to the media. In order to determine if 
Caspase-11-dependent cell death was occurring through a morphologically similar pathway, we 
added 20mM glycine at 4h post S. typhimurium ΔsifA infection. LDH release was determined 4h 
later (total of 8h infection).   
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Figure 2.9. Caspase-11 protects against cytosolic bacteria in vivo. 
(A and B) S. typhimurium or S. typhimurium ∆sifA were injected i.p. into C57BL/6 (1000 cfu) or 
Casp1
–/–
Casp11
–/–
 mice (250 cfu) and survival was monitored. (C to E) The indicated mice were 
infected with 5x10
4
 cfu of both wild type S. typhimurium and S. typhimurium ∆sifA marked with 
ampicillin or kanamycin resistance, respectively. Bacterial loads from 3-4 mice per genotype 
were determined 48h later and competitive index calculated (CI = log (S. typhimurium ∆sifA/ S. 
typhimurium)). A CI of −1 corresponds to 10 cfu of S. typhimurium for every 1 cfu of S. 
typhimurium ∆sifA. (F and G) C57BL/6, Casp1–/–Casp11–/–, or Casp11–/– mice were infected 
with (F) 2x10
7
 cfu mouse passaged B. thailandensis i.p. or (G) 100 cfu B. pseudomallei i.n. (A, 
B, F, G) Data are pooled from two independent experiments. (C to E) Representative of 2 
experiments. For number of mice in each panel see table S2. Statistically significant differences 
with respect to controls are indicated (Student's t test or log rank test for survival; * = p ≤ 0.05, 
n.s. = p > 0.05).  
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Name of Strain Designation Notes Reference 
S. typhimurium ATCC 14028s  wild type www.atcc.org 
S. typhimurium CS401 14028s strep
R
, 
phoN::Tn10dCm 
Samuel I Miller 
S. typhimurium ∆sifA JAF57   CS401 ∆sifA (42) 
S. typhimurium ∆sifA 
flgB 
JAF57 flgB CS401 ∆sifA 
flgB44::Tn10 
S. Yamaguchi 
B. thailandensis  E264 wild type www.atcc.org 
B. thailandensis  E264-1 mouse passaged wild 
type 
this study 
B. thailandensis T3SS 
mutant 
  Joseph Mougous 
B. thailandensis T6SS 
mutant 
  Joseph Mougous 
B. pseudomallei  Bp340 1026b amrRAB-oprA (43) 
B. pseudomallei 
∆purM 
 
Bp82 purine auxotroph (44) 
 
L. pneumophila LP02 wild type; 
Philadelphia-1 rpslL 
hsdR thyA
-
 
(46) 
 
L. pneumophila ∆flaA  flagellin mutant (47) 
L. pneumophila ∆flaA 
∆sdhA 
 flagellin, sdhA mutant (48) 
    
Plasmids Resistance Notes  
pWSK29 Amp Low copy vector (45) 
pWSK129 Kan Low copy vector (45) 
Table 2.1.  Strain and plasmid list. 
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Figure Mice genotype Number 
of mice 
Fig.1C C57Bl/6 21 
 Nlrc4
−/−
 15 
 Casp1
−/−
Casp11
−/−
 21 
Fig.1d Nlrc4
−/−
Asc
−/−
 10 
 Casp1
−/−
Casp11
−/−
 5 
Fig.1E C57Bl/6 10 
 Il1b
−/−
Il18
−/−
 10 
 Casp1
−/−
Casp11
−/−
 10 
Fig.4A C57Bl/6 – S. typhimurium 10 
 C57Bl/6 – S. typhimurium ∆sifA 9 
Fig.4B Casp1
−/−
Casp11
−/−
 – S. typhimurium  9 
 Casp1
−/−
Casp11
−/−
 – S. typhimurium ∆sifA 9 
Fig.4F C57Bl/6 7 
 Casp1
−/−
Casp11
−/− 
16 
 Casp11
−/− 
17 
Fig.4G C57Bl/6 8 
 Casp1
−/−
Casp11
−/− 
10 
 Casp11
−/− 
11 
Fig. 2.3A C57Bl/6 5 
 Casp1
−/−
Casp11
−/−
 5 
Fig. 2.3B C57Bl/6 5 
 Casp1
−/−
Casp11
−/−
 8 
 Nlrc4 10 
 Asc
−/−
 7 
 Nlrp3
−/−
 9 
 Nlrc4
−/−
Asc
−/−
 9 
Fig. 2.3C Il1b
−/−
Il18
−/−
 19 
 Casp1
−/−
Casp11
−/−
 10 
Table 2.2.  Numbers of mice used in survival experiments 
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CHAPTER 3: CYTOPLASMIC LPS ACTIVATES CASPASE-11: IMPLICATIONS IN 
TLR-4 INDEPENDENT ENDOTOXIC SHOCK
5
 
 
SUMMARY 
Inflammatory caspases, such as caspase-1 and -11, mediate innate immune detection of 
pathogens. Caspase-11 induces pyroptosis, a form of programmed cell death, and specifically 
defends against bacterial pathogens that invade the cytosol. During endotoxemia, however, 
excessive caspase-11 activation causes shock. We report that contamination of the cytoplasm by 
lipopolysaccharide (LPS) is the signal that triggers caspase-11 activation in mice. Specifically, 
caspase-11 responds to penta- and hexa-acylated lipid A, whereas tetra-acylated lipid A is not 
detected, providing a mechanism of evasion for cytosol-invasive Francisella. Priming the 
caspase-11 pathway in vivo resulted in extreme sensitivity to subsequent LPS challenge in both 
wild type and Tlr4-deficient mice, whereas caspase 11-deficient mice were relatively resistant. 
Together, our data reveal a new pathway for detecting cytoplasmic LPS.  
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CYTOPLASMIC LPS ACTIVATES CASPASE-11: IMPLICATIONS IN TLR-4 
INDEPENDENT ENDOTOXIC SHOCK 
 
Caspases are evolutionarily ancient proteases that are integral to basic cellular 
physiology.  Although some caspases mediate apoptosis, the inflammatory caspases-1 and -11 
trigger pyroptosis, a distinct form of lytic programmed cell death. In addition, caspase-1 
processes IL-1 and IL-18 to their mature secreted forms. Caspase-1 is activated by the 
canonical inflammasomes, which signal via the adaptor ASC; NLRC4 and NLRP1a/1b can 
additionally activate caspase-1 directly (1, 2). In contrast to caspase-1, caspase-11 is activated 
independently of all known canonical inflammasome pathways; the hypothetical caspase-11 
activating platform has been termed the non-canonical inflammasome (3). Casp1
–/–
 mice 
generated from 129 background stem cells are also deficient in Casp11 due to a passenger 
mutation backcrossed from the 129 background into C57BL/6. Caspase-11 is responsible for 
certain phenotypes initially attributed to caspase-1, such as shock following endotoxin challenge 
(3). The physiologic function of caspase-11 is to discriminate cytosolic from vacuolar bacteria 
(4). In the absence of caspase-11, mice become acutely susceptible to infection by bacteria that 
escape the phagosome and replicate in the cytosol (4), such as Burkholderia pseudomallei and B. 
thailandensis. Caspase-11 also responds to vacuolar Gram-negative bacteria, albeit with delayed 
kinetics (3, 5-7), which may have relevance to its aberrant activation during sepsis. Although 
these studies demonstrated both detrimental and protective roles for caspase-11, the precise 
nature of the caspase-11 activating signal remained unknown. 
 Because caspase-11 specifically responds to cytosolic bacteria, we hypothesized that 
detection of a conserved microbial ligand within the cytosol triggers caspase-11. To address this 
hypothesis, we generated lysates of Gram-negative and Gram-positive bacteria and transfected 
them into LPS primed Nlrc4
–/–
Asc
–/–
Casp11
+/+
 or Casp1
–/–
Casp11
–/–
 bone marrow-derived 
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macrophages (BMMs). By comparing these strains, we can examine caspase-11 activation in the 
absence of canonical inflammasome detection of flagellin and DNA (Fig. 3.1). Although boiled 
Gram-negative bacterial lysates were detected through caspase-11 upon transfection into BMMs, 
Gram-positive lysates were not (Fig. 3.2A). RNase, DNase, lysozyme, and proteinase K 
digestion was sufficient to dispose of canonical inflammasome agonists, but failed to eliminate 
the caspase-11 activating factor(s) (Fig. 3.2B). We then treated boiled lysates with ammonium 
hydroxide, which is known to deacylate lipid species (8), and observed that the caspase-11 
activating factor was degraded, whereas canonical inflammasome agonists persisted (Fig. 3.2C).  
These results suggested lipopolysaccharide (LPS) as the caspase-11 agonist. Consistent 
with this hypothesis, BMMs underwent caspase-11 dependent pyroptosis following transfection 
of ultra pure Salmonella minnesota RE595 LPS (Fig. 3.2D). Caspase-11 can promote IL-1 
secretion by triggering the canonical NLRP3 pathway (3) (Fig. 3.1). Consistently, IL-1 
secretion and caspase-1 processing following transfection of LPS were also caspase-11 
dependent (Fig. 3.2, E to G). Moreover, caspase-11 alone promoted pyroptosis (Fig. 3.2H).  In 
contrast to caspase-1, we were unable to convincingly visualize caspase-11 processing by 
western blot (Fig. 3.2, F and G; Fig. 3.3A), despite the vast majority of cells exhibiting 
pyroptotic morphology as seen by phase microscopy.  Although these data do not exclude the 
possibility that processing of a small amount of caspase-11 is required for pyroptosis, they do 
indicate that processing is not a good proxy measure for rapid caspase-11 activation. This is 
consistent with direct caspase-1 activation by NLRC4, which is not accompanied by processing 
(9).  These results suggest that the presence of LPS in the cytosol is sufficient to trigger caspase-
11; however, we cannot rule out the formal possibility that this signaling arises from a membrane 
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bound compartment such as the ER or golgi.  Future identification of the non-canonical 
inflammasome will permit this determination. 
The caspase-11 pathway is not responsive unless macrophages are previously stimulated 
(primed) with either LPS, poly(I:C), IFN-, or IFN-, which likely induces multiple components 
of the non-canonical inflammasome pathway including caspase-11 (Fig. 3.3B) (4-7, 10). LPS 
and poly(I:C) prime via TLR4 and TLR3, respectively, which both stimulate IFN- production; 
IFN- and IFN- signaling overlap in their activation of the STAT1 transcription factor, which is 
critical to caspase-11 activation (5, 7). In order to separate the priming and activation stimuli of 
caspase-11, we verified that poly(I:C) and IFN- could substitute for LPS as priming agents (Fig. 
3.2I). 
To corroborate our LPS transfection results, we sought another means to deliver LPS to 
the cytoplasm. Listeria monocytogenes lyses the phagosome via the pore forming toxin LLO, 
and as a Gram-positive bacterium does not contain LPS.  L. monocytogenes infection did not 
activate caspase-11 in BMMs; however, co-phagocytosis of wild type, but not LLO mutant 
(∆hly), L. monocytogenes with exogenous LPS triggered pyroptosis, IL-1 secretion, and 
caspase-1 processing dependent upon caspase-11 (Fig. 3.4, A-F). Despite this genetic evidence 
of caspase-11 activation, we again did not observe proteolytic processing of caspase-11 (Fig. 3.4, 
E and F).  In conjunction with our previous data indicating that caspase-11 discriminates 
cytosolic from vacuolar Gram-negative bacteria (4), these results indicate that detection of LPS 
in the cytoplasm triggers caspase-11 dependent pyroptosis. 
Previous studies have shown that another agonist, cholera toxin B (CTB), activates 
caspase-11.  However, LPS was present with CTB for the duration of these experiments (3), and 
caspase-11 failed to respond to CTB in the absence of LPS (Fig. 3.4G). The physiological 
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function of CTB is to mediate the translocation of the enzymatically active cholera toxin A 
(CTA) into host cells. Therefore, we hypothesized that activation of caspase-11 by CTB results 
from delivery of co-phagocytosed LPS into the cytosol.  Under this hypothesis, CTB should 
likewise be able to shuttle canonical inflammasome agonists, which are detected in the cytosol. 
Indeed, when LPS was replaced with PrgJ, an NLRC4 agonist (11), the pyroptotic response 
switched from caspase-11-dependence to NLRC4-dependence (Fig. 3.4G). Therefore, in these 
experiments CTB is not a caspase-11 agonist, but rather an LPS delivery agent. Whether CTB 
disrupts vacuoles during its use as an adjuvant, or whether complete cholera toxin (CTA/CTB) 
disrupts vacuoles during infection with Vibrio cholera remain to be examined. 
  We next examined the LPS structural determinants required for detection through 
caspase-11, and found that the lipid A moiety alone was sufficient for activation (Fig. 3.5A).  It 
is well established that lipid A modifications enable TLR4 evasion, and we therefore 
hypothesized that cytosolic pathogens could evade caspase-11 by a similar strategy.  Indeed, 
Francisella novicida, a Gram-negative cytosolic bacteria, was not detected by caspase-11 (no 
signal in Nlrc4
–/–
Asc
–/–
 BMMs; Fig. 3.5B). F. novicida lysates containing DNA activated 
caspase-1; however, after DNase digestion the remaining LPS failed to activate caspase-11, 
which was not restored by temperature-dependent alterations in acyl chain length (12) (Fig. 
3.5C). As with L. monocytogenes, co-phagocytosis of F. novicida with exogenous S. minnesota 
LPS resulted in caspase-11 activation (Fig. 3.5D). Together, these results suggest that 
Francisella species evade caspase-11 by modifying their lipid A. Francisella species have 
peculiar tetra-acylated lipid A unlike the hexa-acylated species of enteric bacteria (13). F. 
novicida initially synthesizes a penta-acylated lipid A structure with two phosphates and then 
removes the 4’ phosphate and 3’ acyl chain in reactions that do not occur in lpxF mutants (14, 
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15) (Fig. 3.5E). Conversion to the penta-acylated structure restored caspase-11 activation, 
whereas other modifications that maintained the tetra-acylated structures (flmK mutant or 18°C 
growth (12, 16)) did not (Fig. 3.5F). lpxF mutant lipid A is not detected by TLR4 (14), 
suggesting that the TLR4 and caspase-11 pathways have different structural requirements. 
Deacylation of lipid A is a common strategy employed by pathogenic bacteria. For 
example, Yersinia pestis removes two acyl chains from its lipid A upon transition from growth at 
25°C to 37°C (17) (Fig. 3.5G). Consistent with our structural studies of F. novicida lipid A, 
caspase-11 detected hexa-acylated lipid A from Y. pestis grown at 25°C, but not tetra-acylated 
lipid A from bacteria grown at 37°C (Fig. 3.5H). Together, these data indicate that caspase-11 
responds to distinct lipid A structures, and pathogens appear to exploit these structural 
requirements in order to evade caspase-11.   
 In addition to detection of extracellular/vacuolar LPS by TLR4, our data indicate that an 
additional sensor of cytoplasmic LPS activates caspase-11.  These two pathways intersect, 
however, because TLR4 primes the caspase-11 pathway.  However, Tlr4
–/–
 BMMs responded to 
transfected or CTB-delivered LPS after poly(I:C) priming (Fig. 3.6, A-C). Therefore, caspase-11 
can respond to cytoplasmic LPS independently of TLR4. 
In established models of endotoxic shock, both Tlr4
–/–
 and Casp11
–/–
 mice are resistant to 
lethal challenge with 40-54 mg/kg LPS (3, 18, 19), whereas WT mice succumb in 18 to 48 hours 
(Fig. 3.6D). We hypothesized that TLR4 detects extracellular LPS and primes the caspase-11 
pathway in vivo.  Then, if high concentrations of LPS persist, aberrant localization of LPS within 
the cytoplasm could trigger caspase-11, resulting in the generation of shock mediators. We 
sought to separate these two events by priming and then challenging with otherwise sublethal 
doses of LPS. C57BL/6 mice primed with LPS rapidly succumbed to secondary LPS challenge 
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in 2 hours (Fig. 3.6D). TLR4 was required for LPS priming, as LPS primed Tlr4
–/–
 mice survived 
secondary LPS challenge (Fig. 3.6E). To determine whether alternate priming pathways could 
substitute for TLR4 in vivo, we primed mice with poly(I:C), and observed that both C57BL/6 
and Tlr4
–/–
 mice succumbed to secondary LPS challenge (Fig. 3.6E).  This was concomitant with 
hypothermia (Fig. 3.6F), seizures, peritoneal fluid accumulation, and occasionally intestinal 
hemorrhage. In contrast, poly(I:C) primed Casp11
–/–
 mice were more resistant to secondary LPS 
challenge (Fig. 3.6G), demonstrating the consequences of aberrant caspase-11 activation.  
Collectively, our data indicate that activation of caspase-11 by LPS in vivo can result in rapid 
onset of endotoxic shock independent of TLR4. 
Mice challenged with the canonical NLRC4 agonist flagellin coupled to the cytosolic 
translocation domain of anthrax lethal toxin also experience a rapid onset of shock (20). In this 
model, NLRC4-dependent caspase-1 activation triggers lethal eicosanoid production via COX-1 
with similar kinetics to our prime-challenge model, suggesting convergent lethal pathways 
downstream of caspase-1 and caspase-11.  Indeed, the COX-1 inhibitor SC-560 rescued 
poly(I:C) primed mice from LPS lethality (Fig. 3.6H). 
Although physiological activation of caspase-11 is beneficial in defense against cytosolic 
bacterial pathogens (4), its aberrant hyperactivation becomes detrimental during endotoxic 
shock. Our data suggest that when LPS reaches critical concentrations during sepsis, aberrant 
LPS localization occurs, activating cytosolic surveillance pathways. Clinical sepsis is a more 
complex pathophysiologic state, where multiple cytokines, eicosanoids, and other inflammatory 
mediators are likely to be hyperactivated. Eicosanoid mediators and other consequences of 
pyroptotic cellular lysis (21) should be considered in future therapeutic options designed to treat 
Gram-negative septic shock.  This underscores the concept that Gram-negative and Gram-
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positive sepsis may cause shock via divergent signaling pathways (22), and that treatment 
options should consider these as discreet clinical entities. 
 
MATERIALS AND METHODS 
Mice and in vivo challenges  
Wild-type C57BL/6 (Jackson Laboratory), Nlrc4
–/–
Asc
–/–
 (23, 24), Casp1
–/–
Casp11
129mt/129mt
 referred to as Casp1
–/–
Casp11
–/–
 (25), Casp11
−/−
 (3), Tlr4
lps-del/lps-del
 referred to 
as Tlr4
–/–
 (Jackson # 007227) mice were used in this study.  Mice were housed in a specific 
pathogen–free facility. All protocols were approved by the Institutional Animal Care and Use 
Committee at the University of North Carolina at Chapel Hill and met guidelines of the US 
National Institutes of Health for the humane care of animals. 
For study of lethal endotoxia, mice were challenged via intraperitoneal (i.p.) injection 
with the indicated quantities of LPS in OptiMEM. To prepare LPS challenge doses, serial 
dilutions of 1mg/mL LPS were carried out, where each dilution was allowed to equilibrate at 
room temperature for at least 5 minutes before further dilution. In some experiments, mice were 
primed with LPS (400g/kg) or poly(I:C) (10g/kg) for 6-8 hours. In COX-1 inhibition 
experiments, mice were given SC-560 (5 mg/kg, Calbiochem) 1 hour prior to LPS challenge. In 
some experiments, rectal temperatures were recorded at the indicated time points using a 
MicroTherma 2T thermometer (Braintree Scientific) with a lubricated RET-3 probe. The 
presence of blood in the intestinal lumen was confirmed using the Sure-Vue Fecal Occult Blood 
Test (Guaic test). Mice were considered moribund when unable to right themselves. 
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Bacterial growth conditions 
All bacterial strains were grown in Luria-Bertani medium (LB) overnight at 37°C, except 
for L. monocytogenes and F. novicida, which were grown in BHI at 30°C or BHI + 0.1% cystine 
at 37°C, respectively. 
 
Bacterial lysates and lipid A preparation 
 For generation of bacterial lysates, 1mL of overnight culture normalized to an OD600 of 
1.0 was pelleted, resuspended in 50L PBS, and boiled 10 minutes. Insoluble lysate components 
were pelleted at 20,000 x g for 10 minutes, and the supernatant was collected. In some 
experiments, supernatants were treated with DNase (10g/mL), RNase (10g/mL), Proteinase K 
(100g/mL), and/or lysozyme (100g/mL) for 3 hours, or adjusted to contain 30% ammonium 
hydroxide, incubated overnight at room temperature, air-dried, and resuspended in PBS. 
LPS was extracted essentially as previously described (Westphal O, Journal of medicinal 
and pharmaceutical chemistry 1961).  Briefly, 500ml overnight cultures were pelleted at 5000 xg 
for 10 minutes.  Bacterial pellets were then resuspended in 40mL of sterile water and 90% 
aqueous phenol at a 1:1 ratio.  Mixtures were incubated in a rotating oven at 65°C for 1 hour.  
Samples were then cooled on ice for 5 minutes and centrifuged at 3000 xg for 30 minutes.  The 
aqueous layer was transferred to a new tube.  20mL of sterile water was then added to the phenol 
layer, mixed, and the aqueous layer extracted a second time.  The aqueous fractions were 
combined and then dialyzed for 24 hours against water in 1000 MWC tubing.  After dialysis, 
insoluble material was removed by centrifugation at 17,000 xg for 20 minutes.  The LPS sample 
was then frozen and lyophilized overnight.  The dried sample was resuspended in 10mL of 
10mM Tris, pH 8.0 containing 25g/mL RNaseI and 100g/mL DNaseI and incubated for 2 
55 
hours at 37°C.  To digest protein, Proteinase K was added at 100g/mL and the incubation was 
continued at 37°C for 2 additional hours.  5mL of water-saturated phenol was then added and the 
mixture was centrifuged at 3000 xg for 30 minutes.  The aqueous layer was removed and 
dialyzed for 24 hours against water in 1000 MWC tubing.  The final LPS sample was then frozen 
and lyophilized overnight.   
To liberate lipid A from the core and O-antigen of LPS, 500L of 10mM sodium acetate 
+ 1% SDS was added to the dried LPS sample.  This mixture was incubated at 100°C for 1 hour.  
This sample was then frozen and lyophilized overnight.  The dried sample was resuspended in 
100L of water along and then added to 1mL of acidified ethanol (100L 4N HCl in 20 mL of 
95% ethanol).  This sample was then centrifuged at 5000 xg for 5 minutes and the supernatant 
discarded.  The sample was then washed with 1mL of 95% ethanol 3 times (centrifugation at 
5000 x g for 5 minutes between washes, supernatant discarded) to remove residual SDS. 
Following the last centrifugation step, the remaining pellet was resuspended in 500L of water 
and lyophilized overnight. 
Contaminating lipids were removed following the protocol of Folch et al. (Folch J, JBC, 
1957) Briefly, lipid A sample was resuspended 1-2% in chloroform/methanol (2:1).  Samples 
were vortexed for 1 minute and then centrifuged at 10,000 xg for 10 minutes at 4°C.  
Supernatants were removed and then this extraction step was repeated. The remaining pellet was 
suspended in 500L of water and lyophilized overnight. 
Contaminating proteins were removed following the protocol of Hirschfeld et al.  
(Hirschfeld, JI, 2000). Briefly, 5mg of lipid A was resuspended in 1mL of water containing 0.2% 
triethylamine (TEA).  Deoxycholate (DOC) was added to a final concentration of 0.5% and 
followed addition of 500L of water-saturated phenol.  Samples were vortexed for 5 minutes and 
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then the phases were allowed to separate at room temperature for 5 minutes.  Samples were 
cooled on ice and then centrifuged at 10,000 xg for 2 minutes.  The aqueous layer was removed 
to a new tube and the phenol layer was reextracted with 500L of water containing 0.2%TEA 
and 0.5% DOC.  The aqueous layers were pooled and adjusted to contain a final concentration of 
75% ethanol and 30mM sodium acetate. The sample was then allowed to precipitate at -20°C for 
1 hour.  Precipitates were centrifuged at 10,000 xg for 10 minutes at 4°C, washed in 100% 
ethanol and then air-dried.  The precipitates were then resuspended in 500L of water containing 
0.2% TEA and lyophilized overnight. 
 
Liposome preparation and transfections 
 Bacterial lysate transfection complexes were generated as follows: For transfection of 
5x10
4
 BMMs, 0.25L lysate suspended in 25L OptiMEM and 0.25L Lipofectamine 2000 
suspended in 25L were allowed to equilibrate at room temperature for 5 minutes. Suspensions 
were mixed and incubated at room temperature for 20 minutes. For LPS and lipid A transfection 
complexes, 75ng of LPS or lipid A suspended in 2L OptiMEM and 375ng DOTAP suspended 
in 2L OptiMEM were allowed to equilibrate at room temperature for 5 minutes. Suspensions 
were the mixed and incubated for 30 minutes at room temperature. Reaction volumes were then 
brought up to 50L with OptiMEM. 
 
Macrophage culture, treatment, and analysis of inflammasome activation  
BMMs were prepared as described (26). For experiments, macrophages were seeded into 
96-well tissue culture treated plates at a density of 5x10
4
 cells/well. When indicated, 
macrophages were primed with lipopolysaccharide (50 ng/ml), poly(I:C) (1g/mL) or IFN-γ (8 
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ng/ml ) overnight. For infections, culture media was replaced with OptiMEM and then bacteria 
were added to BMMs at MOI 200 (F. novicida) or MOI 5 (L. monocytogenes), centrifuged for 5 
min at 200 x g, and incubated at 37°C. After 1 hour, extracellular bacterial growth was stopped 
by addition of 20 μg/ml gentamicin. In some experiments, 1g/mL LPS or lipid A was included 
during the infection. For transfections, culture media was replaced with OptiMEM and then LPS 
and lysate transfection complexes were added to BMMs and centrifuged for 5 min at 200 x g. 
For CTB experiments, macrophages were primed for 5h with poly(I:C) and Pam3CSK4 
(100g/mL). Media was replaced with OptiMEM containing poly(I:C), Pam3CSK4, and 
combinations of CTB, LPS, and PrgJ as indicated in the figure legends. Supernatant samples 
were collected at the indicated time points. Cytotoxicity was defined as the percentage of total 
lactate dehydrogenase released into the supernatant and was determined as described (27). IL-1β 
secretion was determined by enzyme-linked immunosorbent assay (ELISA) (R&D Systems). 
PrgJ was purified as described (11). S. minnesota LPS was obtained from List Biologicals.  E. 
coli O111:B4 LPS was from Sigma. 
 
Complementation and knockdown of Casp1 and Casp11 
Bone marrow derived macrophages were immortalized (iBMM) as described (28). For 
complementation of Casp1 and Casp11 in Casp1
–/–
Casp11
–/–
 iBMMs, macrophages were 
transduced with pMXsIP (29) derived retrovirus carrying Casp1 or Casp11. 
 
Western blots 
Total protein from lysates and supernatants of 5 x 10
4
 cells was analyzed by Western blot. 
Caspase-11 content and processing was analyzed using anti-caspase-11 antibody (17D9, Novus) 
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diluted 1:500. Caspase-1 processing was determined using an anti-caspase-1 antibody (clone 
4B4, Genentech). Blots were stripped and equivalent loading of protein was ensured by Western 
blot using anti-β-actin HRP antibody (Cat. # 20272, AbCam) diluted 1:20,000. 
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FIGURES AND TABLES 
 
 
 
Figure 3.1. Schematic of canonical and non-canonical inflammasome pathways.  
The canonical inflammasomes (shown here: NLRP3, AIM2, and NLRC4) activate caspase-1, 
whereas a hypothetical non-canonical inflammasome activates caspase-11. Both caspase-1 and 
caspase-11 initiate pyroptosis. Via its CARD domain, NLRC4 can directly bind caspase-1 to 
mediate its activation. In contrast, Pyrin domain containing inflammasomes, such as NLRP3 and 
AIM2, cannot directly bind caspase-1; rather, they interact indirectly via the adaptor protein 
ASC, which polymerizes into a structure called the ASC focus. Caspase-1 processes IL-1 and 
IL-18 to their mature secreted forms in the ASC focus.  In contrast, caspase-11 does not process 
IL-1 alone, rather it activates the NLRP3/ASC/caspase-1 pathway (arching arrow). In the 
absence of Nlrc4 and Asc, macrophages are unable to signal via any known canonical 
inflammasome pathways; however, they retain the ability to activate caspase-11, which functions 
independently of the canonical inflammasomes. Casp1
–/–
Casp11
–/–
 macrophages, on the other 
hand, are deficient in all inflammasome pathways. 
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Figure 3.2. Cytoplasmic LPS triggers caspase-11 activation.  
(A-H) BMM were LPS primed overnight prior to transfection.  (A-C) BMMs were transfected 
with the indicated bacterial lysates packaged in Lipofectamine 2000.  Cytotoxicity was 
determined by lactate dehydrogenase release 4 hours later. Where indicated, lysates were treated 
with RNase, DNase, proteinase K, and lysozyme (RDLP) (B) or ammonium hydroxide (C). (D-
E) BMMs were transfected with ultrapure LPS from S. minnesota RE595 packaged with 
DOTAP, a liposomal transfection reagent. Cytotoxicity (D) and IL-1 secretion by ELISA (E) 
were determined 4 h post transfection. (F-G) BMMs were stimulated as in (D) and caspase-1 and 
-11 processing by western blot were examined 2 h post transfection. (H) Immortalized Casp1
–/–
Casp11
–/–
 BMMs (iBMMs) complemented by retroviral transduction of Casp1 or Casp11 were 
transfected with LPS from S. minnesota RE595. Cytotoxicity was determined after 4 h. (I) 
Macrophages were primed overnight with LPS (50ng/mL), poly(I:C) (1g/mL), IFN-γ (8ng/mL), 
or left untreated. Cells were then transfected with LPS from S. minnesota RE595 and 
cytotoxicity was determined 2 h later. Data are representative of at least 3 experiments. Error 
bars indicate standard deviation of technical replicates. 
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Figure 3.3. Upregulation of caspase-11 potentiates pyroptosis but not proteolytic 
processing.  
(A, left) Overexposure of caspase-11 western blot from Fig. 3.2F reveals minor processing of 
caspase-11 in LPS primed C57BL/6 BMMs 2 hours after transfection with LPS. (A, right) Nlrc4
–
/–
Asc
–/–
 BMMs (2 x 10
5
 
three freeze thaw cycles.  Insoluble components were pelleted and supernatants were then 
incubated for 5 minutes at 37°C. SDS-sample buffer was added to the reaction and then 
processed for western blotting.  Significant spontaneous processing was observed in the lysates. 
Interpretation of (A, left): Although the minor processed band observed after LPS transfection 
could represent caspase-11 processing in response to cytoplasmic LPS, it could also be due to 
spontaneous processing that occurs in the media after pyroptotic cell lysis. (B) Upregulation of 
full-length caspase-11 in unprimed BMMs, or BMMs primed overnight with LPS (50ng/mL), 
poly(I:C) (1000ng/mL), or IFN-γ (8ng/mL), as revealed by western blot. 
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Figure 3.4. Listeria and CTB mediate caspase-11 activation by LPS.  
(A-F) The indicated macrophages were primed with poly(I:C) or LPS and then infected by L. 
monocytogenes (MOI 5) in the presence or absence of LPS from S. minnesota 
Cytotoxicity (A, C, D), IL-1 secretion (B), or caspase-1 and caspase-11 processing (E-F) were 
examined 4 h post-infection. (G) Poly(I:C) and Pam3CSK4 primed macrophages were incubated 
E. coli 
 Data are representative of 3 (A, D, G) 
or 2 (B, C, E, F) experiments. Error bars indicate standard deviation of technical replicates. 
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Figure 3.5.Caspase-11 responds to distinct lipid A structures.  
(A) Poly(I:C) primed BMMs were transfected with LPS from S. minnesota RE595 or S. 
typhimurium lipid A. Cytotoxicity was determined after 2 h. (B) Cytotoxicity in LPS primed 
BMMs was determined 4 hours after infection with F. novicida (MOI 200). (C) LPS primed 
BMMs were transfected with mock or DNase treated F. novicida lysates. Cytotoxicity was 
determined 4 hours later. (D) Macrophages were infected as in (B) in the presence or absence of 
LPS from S. minnesota RE595. (E) Structural comparison of lipid A from wild type F. novicida 
or the lpxF mutant. Structural changes are indicated. (F) Poly(I:C) primed macrophages were 
transfected with lipid A from F. novicida grown at 18°C or 37°C, or the indicated F. novicida 
mutants grown at 37°C. Cytotoxicity was determined after 2 h. (G) Structural comparison of 
lipid A from Y. pestis grown at 25°C or 37°C. (H) Poly(I:C) primed BMMs were infected with L. 
monocytogenes in the presence of lipid A from Y. pestis grown at 25°C or 37°C. Cytotoxicity 
was determined after 4 h. Data are representative of at least 3 (A, F, G) or 2 (B, C, D) 
experiments. Error bars indicate standard deviation of technical replicates. 
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Figure 3.6. LPS detection and rapid induction of shock in primed mice occur independently 
of TLR4. 
(A) BMMs were primed overnight with poly(I:C) and then transfected with S. minnesota RE595 
LPS. Cytotoxicity was determined 2 hours later. (B-C) Poly(I:C) and Pam3CSK4 primed 
macrophages were incubated wit
E. coli B) and IL-1 secretion (C) were determined 16 hours 
later. Data are representative of at least 3 experiments; error bars indicate standard deviation of 
technical replicates (A-C). (D) Survival of mice challenged with the indicated doses of 
Escherichia coli LPS, or primed with LPS and then re-challenged 7 hours later. Data are pooled 
from three experiments; n = 9 per condition. (E) Survival of mice primed with LPS (400μg/kg) 
from three experiments; n = 7 per LPS prime group and n = 8 for poly(I:C) prime group. (F) 
Rectal temperatures of mice in panel (E) after LPS challenge. Data are representative of 3 
experiments; n = 4 per condition. (G) Survival of poly(I:C) primed mice challenged 6 hours later 
with LPS (10ng/kg). Data are pooled from 3 experiments, n = 11 (C57BL/6) or 12 (Casp11
–/–
). 
(H) Mice were primed with poly(I:C) and then challenged 6 hours later with LPS (100ng/kg) and 
monitored for survival. 1 h before LPS challenge, mice were given 5mg/kg of COX-1 inhibitor 
or DMSO control. Data are pooled from 2 experiments; n = 11 per condition. 
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Name of Strain Designation Notes Reference 
S. typhimurium ATCC 14028s  wild type www.atcc.org 
B. thailandensis  E264 wild type www.atcc.org 
P. aeruginosa PAO1   wild type Joseph 
Mougous 
UPEC ATCC 19110 wild type www.atcc.org 
C. rodentium ATCC 51459 wild type www.atcc.org 
S. flexneri M90T wild type Alan Aderem 
L. monocytogenes 10403S  Dan Portnoy 
L. monocytogenes 
hly 
  Dan Portnoy 
L. innocua   www.atcc.org 
B. subtilis   Tony 
Richardson 
S. aureus ATCC25923 wild type www.atcc.org 
S. pyogenes MGAS-5005 wild type Tony 
Richardson 
E. faecalis V583 wild type Tony 
Richardson 
F. novicida U112 wild type www.nwrce.org 
F. novicida lpxF TBE264 lpxF mutant, hexa-
acyl lipid A 
(14) 
 
F. novicida flmK TBE229 flmK mutant, tetracyl 
lipid A 
(16) 
 
Y. pestis KIM6 WT Joe Hinnebusch 
 
Table 3.1. Strain list. 
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CHAPTER 4: LPS POTENTIATES INSULIN-DRIVEN HYPOGLYCEMIC SHOCK
6
 
 
SUMMARY 
 Critically ill patients typically present with hyperglycemia as a result of stress hormone 
and inflammatory cytokine signaling, which induces peripheral insulin resistance over time(1). 
Treating hyperglycemia with insulin improves the survival of patients in intensive care units 
(ICU); however, extreme controversy has surrounded how stringently blood glucose should be 
controlled. The multicenter NICE-SUGAR clinical trial, which enrolled 6104 patients 
investigated whether restoring blood glucose to the normal range with intensive insulin therapy 
(IIT; targeting 81-108 mg/dL) would confer a survival benefit to ICU patients compared to 
conventional insulin therapy (CIT; targeting 144-180 mg/dL)(2). Instead, IIT increased 
mortality. Furthermore, while only 0.5% of patients on CIT experienced extreme hypoglycemia, 
this condition occurred in 6.8% of patients receiving IIT. Subsequent analysis identified both 
moderate and extreme hypoglycemia as independent risk factors for death(3). Amongst 
subgroups of ICU patients, those with sepsis are particularly prone to hypoglycemia during 
IIT(4). Why sepsis predisposes to hypoglycemia remains unknown. Here, we show that co-
delivery of insulin with otherwise sublethal doses of lipopolysaccharide (LPS) induced lethal 
hypoglycemic shock in mice within 1-2 hours. LPS impaired clearance of insulin, which 
                                                          
6
 This chapter contains a manuscript that was submitted for publication in the journal Nature at 
the time of publication here. The full citation is: Hagar, J.A., Edin, M.L., Lih, F.B., Thurlow, L., 
Koller, B.H., Cairns, B.A., Zeldin, D.C., Miao, E.A. LPS potentiates insulin-driven 
hypoglycemic shock. Nature. Submitted for review.  
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amplified insulin receptor and AKT signaling. These effects were mediated by the LPS sensors 
caspase-11 and TLR4 together with the complement system. These three pathways are each 
known or suspected to drive cyclooxygenase (COX)-dependent eicosanoid production(5), and 
certain eicosanoids have been shown to enhance insulin activity(6); accordingly, we found that 
inhibition of COX or prostaglandin E2 prevented the lethal potentiation of insulin activity by 
LPS. Our results raise the possibility that septic patients have impaired insulin clearance, which 
could increase their susceptibility to hypoglycemia during IIT.  Factoring differential insulin 
clearance into insulin administration protocols could minimize the risk of hypoglycemia that 
accompanies IIT, allowing safer study of whether intensive glucose control confers a survival 
benefit relative to conventional glucose control.   
 
LPS POTENTIATES INSULIN-DRIVEN HYPOGLYCEMIC SHOCK 
Excessive activation of the immune system leads to sepsis, characterized by hypotension, 
organ failure, and ultimately death, all of which can be modeled by high dose (54,000 μg/kg) 
lipopolysaccharide (LPS) challenge in mice. Mice deficient in the extracellular/vacuolar LPS 
sensor, TLR4, resist LPS injection(7), as do mice deficient in the cytosolic LPS sensor, caspase-
11, albeit incompletely(8, 9). Caspase-11 is expressed at low levels basally; however, its 
transcription is strongly induced by TLR and interferon signaling (10-13). Whereas poly(I:C) 
primed Tlr4
–/–
 mice uniformly succumb to LPS challenge, Casp11
–/–
 mice are partially resistant, 
depending on the dose(13, 14) (Fig. 4.1a). Only Casp11
–/–
Tlr4
–/–
 mice were completely resistant, 
indicating that caspase-11 and TLR4 account for all of the lethality of this challenge regimen 
(Fig. 4.1a). 
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In vitro, extracellular LPS does not efficiently access the cytosolic sensor caspase-11 
unless it is packaged with a transfection reagent(12, 13). In an attempt to develop a novel model 
of sepsis where LPS is specifically delivered to the cytosol in vivo, we injected mice with LPS 
packaged with a transfection reagent (note that we used OptiMEM as a medium to optimize the 
packaging reaction). To our surprise, poly(I:C) primed mice challenged with 400 μg/kg LPS 
even in the absence of transfection reagents rapidly succumbed to shock, becoming moribund 
within 1 to 2.5 hours of challenge (Fig. 4.2a), and inclusion of the transfection reagent had no 
appreciable effect on this phenotype(not shown). This result starkly contrasted the mortality 
kinetics of poly(I:C) primed mice challenged with 54,000 μg/kg LPS in DPBS, where mice 
succumb in 6-48 hours (Fig. 4.1a), suggesting OptiMEM contributed to the rapid lethality and 
extreme sensitization to low dose LPS. As a control, OptiMEM alone was not sufficient to 
precipitate shock, nor was 400 μg/kg LPS delivered in DPBS or DMEM (Fig. 4.2a, b). Mice 
challenged with LPS in OptiMEM became severely hypothermic (Fig. 4.2c) and exhibited 
seizures atypical of high dose LPS challenge in DPBS. Extreme hypoglycemia can cause 
seizures. Indeed, blood glucose levels of mice challenged with LPS in OptiMEM fell below the 
lower limit of detection (Fig. 4.2d). 
Of the many components in OptiMEM, we hypothesized that insulin synergized with 
LPS to drive shock. Indeed, addition of insulin and LPS to DPBS recapitulated the phenotype of 
mice challenged with LPS in OptiMEM (Fig. 4.1b-d). Furthermore, mice could be rescued by 
administration of glucose, implicating extreme hypoglycemia as the cause of death (Fig. 4.1e). 
Together, these data demonstrate that LPS and insulin synergize to drive hypoglycemic shock. 
Various mechanisms could explain how LPS and insulin could potentiate hypoglycemic 
shock. Insulin had no effect on LPS induced IL-6 or TNF secretion (Fig. 4.3a, b), suggesting that 
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LPS acts upstream of or in parallel to insulin rather than insulin potentiating LPS signaling. LPS 
alone had a minimal effect on blood glucose, suggesting that an additive effect on glucose 
consumption by LPS and insulin signaling pathways cannot fully account for the extreme 
hypoglycemia (Fig. 4.1d). AKT is a node downstream of insulin signaling as well as multiple 
immune signaling pathways; however, LPS alone did not induce appreciable AKT 
phosphorylation (Fig. 4.3c), arguing against the synergistic intersection of immunological and 
insulin signaling pathways at the level of AKT. However, LPS amplified both insulin driven 
AKT and insulin receptor (IR) phosphorylation (Fig. 4.3c-h), indicating LPS acts at or upstream 
of IR. We therefore examined plasma insulin concentrations, observing that mice challenged 
with LPS and insulin together had significantly elevated plasma insulin than mice treated with 
insulin alone (Fig. 4.4a).  
Serum insulin concentration reflects both the rate of insulin absorption into the blood 
from the peritoneal cavity and the rate of clearance by tissues. Absorption of Evan’s blue dye 
was unaffected by LPS (Fig. 4.4b). The majority of insulin is cleared after binding the IR, 
internalization, and subsequent degradation occurring primarily in the liver and kidneys(15). In 
contrast, C-peptide, a fragment of pro-insulin secreted with mature insulin, is cleared in an IR 
independent manner(16). In contrast to its effect on plasma insulin, LPS did not affect 
concentrations of co-injected C-peptide (Fig. 4.3i). These data indicate that LPS impairs 
clearance of insulin; whether this occurs by antagonism of IR internalization, IR recycling, 
and/or insulin degrading enzymes remains to be determined in future studies. This latter 
possibility is consistent with the observation that inhibition of the insulin degrading enzyme is 
known to impair clearance of exogenous insulin, increasing insulin sensitivity(17).  
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 We next examined the contributions of caspase-11 and TLR4 in LPS potentiated insulin 
shock. First, as a control, we determined that Casp11
–/–
, Tlr4
–/–
, and Casp11
–/–
Tlr4
–/–
 mice had 
normal insulin sensitivity in the absence of LPS challenge (Fig. 4.5a). Tlr4
–/–
 mice exhibited 
intermediate resistance to challenge with insulin and 2.5µg/kg LPS (Fig. 4.5b), but uniformly 
succumbed to challenge with insulin and 40 μg/kg LPS (Fig. 4.5c). Whereas Casp11–/– mice 
survived challenge with insulin and 2.5 μg/kg LPS (Fig. 4.5b), they were nevertheless 
completely susceptible to challenge with insulin and 40 μg/kg LPS (Fig. 4.5c). Thus, caspase-11 
appears to exert a more detrimental effect in the model than TLR4. Consistent with this, liver 
AKT and IR phosphorylation were significantly reduced in Casp11
–/–
 mice challenged with 
insulin and LPS 2.5μg/kg, but not in Tlr4–/– mice (Fig. 4.5d-g). Unexpectedly, Casp11–/–Tlr4–/– 
mice were also uniformly susceptible to challenge with insulin and LPS 40 μg/kg (Fig. 4.5c); this 
result is in contrast to the complete resistance of Casp11
–/–
 Tlr4
–/–
 mice to LPS 54,000 µg/kg 
challenge (Fig. 4.1a), indicating that lower dose LPS triggers immune pathways capable of 
enhancing insulin signaling that are not lethal on their own. 
 LPS is known to activate the complement cascade with a potency determined in part by 
the O-antigen structure(18). LPS from E. coli serotype O111:B4 is suggested to have weak but 
appreciable complement activating properties(18). Indeed, depletion of complement with cobra 
venom factor rescued Casp11
–/–
Tlr4
–/–
 mice, but not wild type mice, from challenge with insulin 
and 400 μg/kg LPS (Fig. 4.5h and Fig. 4.6). Altogether, these data suggest that caspase-11, 
TLR4, and the complement cascade act in parallel to enhance insulin signaling. 
 We hypothesized that caspase-11, TLR4, and complement signaling pathways converge 
on common mediators that enhance insulin signaling. The 1-2 h kinetics of hypoglycemic shock 
observed here are consistent with the kinetics of cyclooxygenase (COX) dependent eicosanoid 
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production downstream of TLR4 and complement activation(19). Furthermore, activation of 
caspase-1 induces eicosanoid production(5), suggesting the possibility that caspase-11 may drive 
a similar response. Indeed, inhibition of COX rescues mice challenged with low dose LPS in 
OptiMEM (12)or with insulin (Fig. 4.7a), preventing extreme hypothermia and hypoglycemia 
(Fig. 4.7b, c), inhibiting synergistic phosphorylation of AKT and IR (Fig. 4.7d-g), and improving 
insulin clearance (Fig. 4.7h). However, challenge with insulin and a higher dose of LPS 
overwhelmed the protection afforded by COX inhibition (Fig. 4.8a), suggesting either 
incomplete inhibition or implicating additional, lower potency mediators. Profiling of plasma 
lipid signaling molecules revealed that LPS induced production of the COX metabolites 
prostaglandin E2 (PGE2), PGD2, PGF2α, and 6-keto-PGF1α (Fig. 4.7i). Insulin had no effect on 
prostaglandin production (Fig. 4.7i), further supporting that LPS acts upstream of insulin. The 
magnitude of LPS induced eicosanoid production was not sufficient to affect hematocrit (Fig. 
4.8b), as has been observed during massive systemic caspase-1 activation leading to 
hypovolemic shock(5). Amongst prostaglandins, there is evidence that PGE2 modulates insulin 
signaling(6). Mice deficient in mpges1, a microsomal prostaglandin E synthase largely 
responsible for PGE2 production in response to LPS(20), survived challenge with insulin and 10 
μg/kg LPS (Fig. 4.7j). Together, these data demonstrate that COX and, especially, its 
downstream metabolite PGE2 mediate LPS potentiation of insulin shock.  
Critically ill patients develop insulin resistance and become hyperglycemic(1). Several 
clinical trials suggested a survival benefit to treating hyperglycemic ICU patients with insulin; 
however, the optimal blood glucose window to target had not been rigorously established and 
whether intensive glycemic control provides a survival benefit has been controversial. Thus, the 
NICE-SUGAR trial, the largest and most comprehensive trial examining the benefit of insulin 
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therapy in critical care patients, compared 3050 patients on CIT (targeting 144-180 mg/dL) to 
3054 patients on IIT (targeting 81-108 mg/dL). Contrary to the hypothesized results, patients 
receiving IIT exhibited increased mortality and had an unexpectedly high 6.8% incidence of 
severe hypoglycemia (< 40 mg/dL) compared to 0.5% for CIT(2). This hypoglycemia correlated 
with mortality(3), which was also seen in another study(21). Amongst critically ill patients, those 
with sepsis have a particular predisposition to develop hypoglycemia during IIT; however, the 
underlying mechanism driving this remains unknown. Our data in a murine sepsis model show 
that several innate immune signaling pathways can act in parallel to impair insulin clearance, 
which amplifies its biological effect (see Fig. 4.9 for schematic). If this previously unappreciated 
interaction holds true in patients with sepsis, it could explain their particular risk of developing 
extreme hypoglycemia in response to IIT(4). Therefore, it will be important to understand how 
insulin clearance kinetics differ between sub-populations of critically ill patients in order to 
optimize insulin administration protocols in the ICU. Reducing the risk of extreme hypoglycemia 
would enable safer study of the benefits of IIT in critically ill patients.   
 
MATERIALS AND METHODS 
Mice and in vivo challenges  
Wild-type C57BL/6 (Jackson Laboratory), Casp11
−/−
(9), Tlr4
tm1Aki/tm1Aki
(22) referred to as 
Tlr4
–/–
, Casp11
–/–
Tlr4
–/–
 (crossed for this study), and mpges1
tm1Audoly/tm1Audoly
(20) mice were used 
in this study.  Unless noted, mice were female and between 20-30 g (generally >12 weeks of 
age). Mice were housed in a specific pathogen–free facility and fed Harlan 2920X Irradiated 
Regular chow. Of note: in our previous studies, mice were fed Purina 3000 Irradiated Regular 
chow; mice on this diet were sensitive to significantly smaller quantities of LPS (10-100 ng/kg) 
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when delivered in OptiMEM than mice on the Harlan 2920X diet. During all experiments, mice 
were allowed to feed ad libitum. All protocols were approved by the Institutional Animal Care 
and Use Committee at the University of North Carolina at Chapel Hill and met guidelines of the 
US National Institutes of Health for the humane care of animals. 
In all animal studies, unless noted otherwise, mice were primed by intraperitoneal (i.p.) 
injection with poly(I:C) (10mg/kg, Invivogen, cat #tlrl-picw) in DPBS (250µL total volume) 6h 
before subsequent challenges. For study of lethal endotoxic shock absent insulin, primed mice 
were challenged via i.p. injection with LPS (54mg/kg, Sigma, cat # L3024) in DPBS (500µL 
total volume). A 500µL injection volume was also used when the indicated quantities of LPS 
were delivered in DMEM (Gibco) or OptiMEM (Gibco), and when LPS was co-delivered with 
insulin (100µg/kg) in DBPS. To rescue mice challenged with LPS and insulin, animals were 
given an i.p. injection of 500µL 20% glucose in DPBS 30min post-injection of LPS and insulin. 
In some experiments, mice were injected with C-peptide (50µg/kg, Sigma, cat# C4999) together 
with insulin and LPS or DBPS to determine whether LPS affects insulin clearance specifically 
rather than protein clearance or transport from the peritoneal cavity to the serum generally(23). 
In other experiments, mice were injected with 500µL Evan’s Blue dye solution (0.5%, Sigma, 
cat# 2129) with or without LPS. In pan-COX inhibition experiments, mice were given 
indomethacin (20mg/kg, SigmaI7378-5G )  i.p. in 250µL DBPS 5.5 h after priming and 30min 
before challenge with LPS and insulin. To deplete complement C3 protein, mice were injected 
with 15 µg cobra venom factor (Complement Tech, cat # A150) in 250 µL DPBS 4 h after 
priming and 2h before subsequent LPS and insulin challenge. Rectal temperatures were recorded 
at 1h post challenge using a MicroTherma 2T thermometer (Braintree Scientific) with a 
lubricated RET-3 probe. Glucose concentrations were determined in tail blood using a ReliOn 
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Prime Blood Glucose Monitoring System. Mice were considered moribund when unable to right 
themselves or when seizures were first observed. 
Where survival data are presented, data are pooled from at least 2 experiments as detailed 
in Supplemental Table 1. 
 
Western blots 
Antibodies against the following proteins were used in this study: phospho-AKT 
(Ser473) (Cell Signaling, clone D9E, product #4060), AKT (pan) (Cell Signaling, clone C67E7, 
product # 4691), phospho-Insulin Receptor β (Tyr1150/1151) (Cell Signaling, clone 19H7, 
product # 3024), Insulin Receptor β(Cell Signaling, clone 4B8, product # 3025), and Insulin 
(Cell Signaling, clone L6B10, product #8138).  
For analysis of insulin receptor and AKT phosphorylation in ex vivo samples, tissue 
samples were collected from mice 1h post challenge, placed immediately on dry ice, and stored 
at -80°C. Frozen samples (approximately 100mg tissue) were homogenized in 1mL buffer 
containing 100mM KPO4 and 1% triton X-100 at pH10 using a steel ball and Retsch MM400 
ball mill (30 rps for 1min or until homogenous). Samples were then centrifuged for 10min at 
20,000 x g at 4°C. Total protein content of the supernatant was determined by BCA assay, and 
30µg of supernatant total protein was used for Western blot analysis. Primary antibodies were 
used at 1:1000-1:2000 dilutions. In all figure panels, each lane represents a sample from a 
different mouse. 
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Plasma protein analysis 
 Cardiac blood was collected from mice at 1h post challenge (approximately 500µL), 
mixed with 6µL 10kU/mL heparin (Sigma, cat #H3393-10KU), and centrifuged at 20,000 x g for 
1 minute. From this, the serum supernatant was obtained. ELISA was used to determine insulin 
(Genway Biotech, product # GWB-D9B0E) and C-peptide (Sigma, product # SE120040) 
concentrations according to manufacturer instructions. ELISA was also used to determine IL-6, 
and TNF concentrations in plasma (R&D Systems, cat # DY406, and DY410, respectively). 
Alanine aminotransferase (ALT) concentration was determined by colorimetric assay (Cayman 
Chemical, product # 700260).  
 
Determination of Evan’s blue dye serum concentrations 
For determination of Evan’s Blue concentrations, 5µL of serum collected from tail blood 
at the indicated time points was incubated with 45µL formamide at 55°C overnight. After 
incubation, samples were centrifuged at 20,000 x g for 1min, supernatants collected and then 
measured for absorbance at 610nm; values were compared to those of a standard curve to 
determine the concentration of dye in serum. 
 
Determination of plasma eicosanoids 
Eicosanoid metabolites were extracted from mouse plasma by liquid:liquid extraction 
into ethyl acetate and quantified by HPLC-MS/MS. 200 µL plasma was acidified with 200 μL of 
0.1% acetic acid in 5% methanol and spiked with internal standard 3 ng PGE2-d4 (Cayman 
Chemical, Detroit MI). The aqueous mixture was extracted twice with 2 ml ethyl acetate (sigma). 
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The organic phase from both extractions was combined into glass tubes with 6 μL 30% glycerol 
in methanol. Ethyl acetate was evaporated in a speed-vac at 37°C.  
Liquid chromatography of extracted samples was performed with an Agilent 1200 Series 
capillary HPLC (Agilent Technologies, Santa Clara, CA) as previously described(24). Samples 
were reconstituted in 50 µl of 30% ethanol and injected in triplicate, 10 µL injections. 
Separations were achieved using a Halo C18 column (2.7 µm, 100 x 2.1 mm; MAC-MOD 
Analytical, Chadds Ford, PA), which was held at 50°C and a flow rate of 400 µL/min. Mobile 
phase A was 0.1% acetic acid in 85:15 water:acetonitrile. Mobile phase B was 0.1% acetic acid 
in acetonitrile. Gradient elution was used and the mobile phase was varied as follows: 20% B at 
0 min, ramp from 0 to 5 min to 40% B, ramp from 5 to 7 min to 55% B, ramp from 7 to 13 min 
to 64% B. From 13 to 19 min the column was flushed with 100% B at a flow rate of 550 µL/min 
before being returned to starting conditions and equilibrated for 6 minutes.  
Electrospray ionization tandem mass spectrometry was used for detection. Analyses were 
performed on an MDS Sciex API 3000 equipped with a TurboIonSpray source (Applied 
Biosystems, Foster City, CA). Turbo desolvation gas was heated to 425°C at a flow rate of 6 
L/min. All analytes were monitored simultaneously in a scheduled multiple reaction monitoring 
experiment as negative ions at parent ion-product ion mass/charge ratio pairs and retention times. 
The relative response ratios of each analyte and surrogate internal standard were used to 
calculate concentrations compared to response ratios of a range of prostaglandin standards of 
known concentrations (0.1-120 pg/µL injection).  Peak analysis and quantification were 
performed using Analyst software (SCIEX, Framingham, MA). 
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Hematocrit determination 
Tail blood from mice was collected into heparinized capillary tubes (Fisher, cat # 22-362-
566). Tubes were then sealed at one end by flame and centrifuged at 796 x g for 10 minutes. 
Hematocrit ratio was determined as the height of the pelleted cell fraction from the sealed tube 
end compared to the total length of separated blood components. 
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FIGURES AND TABLES 
 
 
 
 
 
Figure 4.1. Co-delivery of LPS and insulin drives hypoglycemic shock.  
a, Survival of poly(I:C) primed mice challenged with LPS (54,000 µg/kg). b, Survival of mice 
challenged with LPS (400 µg/kg), insulin, or both. c, d, Core temperatures (c) and blood glucose 
concentrations (d) of mice 1 h after challenge as in (b). e, Survival of mice after challenge with 
LPS (400 µg/kg) and insulin and subsequent control or glucose injection. All data were pooled 
from 2 independent experiments. Error bars, mean ± SD. Statistically significant differences 
were determined by ANOVA and Bonferroni’s multiple comparison test.  
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Figure 4.2. LPS delivered in OptiMEM rapidly induces shock.  
a, Survival of mice challenged with LPS (400 µg/kg) in DPBS, DMEM, or OptiMEM. b, 
Survival of mice challenged with OptiMEM with or without LPS (400 µg/kg). c, d, Core 
temperatures (c) and blood glucose concentrations (d) of mice 1 h after challenge with LPS in 
DBPS or OptiMEM as described in (a). Survival data were pooled from 2 experiments. 
Temperature and glucose data are representative of 3 independent experiments. Error bars, mean 
± SD. Statistically significant differences were determined by a 2-tailed unpaired t-test. 
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Figure 4.3. LPS impairs insulin clearance and amplifies insulin receptor signaling.  
a, b, Plasma TNF and IL-6 concentrations from mice 1 h after DBPS injection or challenge with 
LPS (400 µg/kg), insulin, or both. c-h, AKT and IR phosphorylation observed at 1 h by Western 
blot in mice challenged as in (a). i, Plasma insulin and C-peptide concentrations at 1 h in mice 
challenged with insulin and C-peptide with or without LPS. All data are pooled from at least 2 
experiments. Error bars, mean ± SD. Statistically significant differences were determined by a 2-
tailed unpaired t-test. 
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Figure 4.4. LPS delays insulin clearance but does not affect serum Evan’s blue 
concentrations.  
a, Serum insulin concentrations of mice 1 h after challenge with insulin or LPS (400 µg/kg) and 
insulin. Representative of 3 experiments. b, Time course of Evan’s blue dye concentrations in 
the serum of mice challenged with dye alone (DPBS) or dye and LPS (400 µg/kg; LPS). Data are 
pooled from 5 mice per condition. Error bars, mean ± SD. 
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Figure 4.5. LPS enhances insulin signaling via caspase-11, TLR4, and complement.  
a, Blood glucose concentrations over time in mice treated with insulin. b, c,  Survival of mice 
after challenge with insulin and LPS (b, 2.5 µg/kg; c, 40 µg/kg). d-g, Phosphorylation of liver 
AKT (d, e) and IR (f, g) determined by Western blot 1 h after challenge as in (b). h, Survival of 
control or CVF treated mice after challenge with LPS (400 µg/kg) and insulin. Data in all panels 
are pooled from at least 2 experiments. Error bars, mean ± SD. Statistically significant 
differences were determined by a 2-tailed unpaired t-test. 
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Figure 4.6. CVF fails to rescue wild-type mice. 
Survival of mice challenged with LPS (400 µg/kg) and insulin (100 µg/kg) 2 h after mock or 
CVF treatment. 
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Figure 4.7. Eicosanoid signaling acts downstream of LPS to amplify insulin activity.  
a, Survival of DMSO or indomethacin treated mice after challenge with LPS (2.5 µg/kg) and 
insulin. b, c, Core temperatures (b) and blood glucose concentrations (c) of mice 1 h after 
challenge as described in (a). d-g, Phosphorylation of liver AKT (d, e) and IR (f, g) determined 
by Western blot 1 h after challenge as described in (a). h, Plasma insulin concentrations of mice 
1 h after treatment as in (b). i, Plasma prostaglandin concentrations in mice 1h after challenge 
with DBPS, LPS (400 µg/kg), insulin, or LPS and insulin. j, Survival of mice challenged with 
insulin and LPS (10 µg/kg). All data are pooled from at least 2 experiments. Error bars, mean ± 
SD. Statistically significant differences were determined by a 2-tailed unpaired t-test. 
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Figure 4.8. Lethality of LPS and insulin challenge is independent of effects on hematocrit.  
a, Survival of mice challenged with LPS (400 µg/kg) and insulin 30 min after mock or 
indomethacin treatment. b, Hematocrit of mice 1 h after treatment with DBPS, LPS (400 µg/kg), 
insulin (100 µg/kg), or LPS and insulin. Dashed line indicates approximate maximum hematocrit 
observed during FlaTox induced hypovolemic shock by Von Moltke and colleagues(5). All data 
are pooled from at least 2 experiments. Error bars, mean ± SD.  
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Figure 4.9. Proposed interaction of LPS with insulin signaling and clearance pathways.  
Upon injection into mice, LPS activates TLR4 and complement signaling pathways. LPS 
additionally interacts with and activates caspase-11; the cells in which this happens and the 
mechanism by which LPS accesses the cytosol remain to be determined. The net effect of LPS 
interacting with these innate immune sensors is generation of signaling lipids such as PGE2, 
inflammatory cytokines, and cellular damps, all of which likely play a role in impairing 
clearance insulin clearance. The ultimate mechanism of this effect remains to be determined, and 
could include antagonism of IR internalization, which could prevent receptor shutoff; inhibition 
of receptor recycling to the plasma membrane, which could limit the ability of a given cell to 
internalize circulating insulin; and inhibition of enzymes involved in insulin degradation, 
allowing more insulin to cycle back to the plasma membrane during IR recycling(15). With 
insulin clearance impaired and the activation half-life of an IR receptor potentially extended, the 
biological effect of a given insulin molecule is enhanced, leading to excessive blood glucose 
uptake and lethal hypoglycemic shock.  
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Figure Panel Condition Number of mice 
1 A Casp11
–/–
 
Tlr4
–/–
 
Casp11
–/–
Tlr4
–/–
 
9 
4 
5 
E DPBS 
Glucose 
5 
6 
3 A C57BL/6 
Casp11
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Tlr4
–/–
 
Casp11
–/–
Tlr4
–/–
 
6 
5 
6 
5 
B C57BL/6 
Casp11
–/–
 
Tlr4
–/–
 
6 
11 
7 
C Casp11
–/–
 
Tlr4
–/–
 
Casp11
–/–
Tlr4
–/–
 
6 
6 
5 
H DPBS 
CVF 
6 
7 
 
4 A DMSO 
Indomethacin 
9 
7 
 
J C57BL/6 
mpges1
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8 
9 
 
Extended Data 
Figure 
Panel Condition Number of mice 
1 A DPBS 
DMEM 
OptiMEM 
5 
5 
5 
 
 B OptiMEM 
OptiMEM + LPS 
7 
6 
 
3  DBPS 
CVF 
4 
5 
 
4 A DMSO 
Indomethacin 
4 
5 
 
Table 4.1.  Number of mice used in experiments. 
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CHAPTER 5: DISCUSSION 
 
CHAPTER 2 – CASPASE-11 PROTECTS AGAINST BACTERIA THAT ESCAPE THE 
VACUOLE 
 
 The data in Chapter 2 established, for the first time, a physiologically protective role for 
caspase-11 that results in lethality in its absence. We determined that caspase-11 activates 
specifically in response to cytosol invasive Gram-negative bacteria. This response accounts for 
the virulence defect of S. Typhimurium sifA and, more strikingly, is critical for mice to resist 
lethal infection by both the bona fide pathogen B. pseudomallei and the normally avirulent soil 
bacterium B. thailandensis. 
 Two of the major questions not resolved by this work – what ligand or cellular 
perturbation activates caspase-11, and what senses this activating signal – are addressed in the 
discussion of Chapter 3 below. In this section, I discuss the significance of the distinction 
between vacuolar and cytosolic localization of bacteria in their ability to activate caspase-11, the 
role of IFN signaling in caspase-11 activation in response to bacteria, coordination of caspase-11 
activity with canonical inflammasome signaling, and other proposed functions of caspase-11 in 
immunity. 
 
Discriminating vacuolar and cytosolic Gram-negative bacteria 
 Prior to the work detailed in Chapter 2, several studies were published that described 
caspase-11 activation in response to diverse Gram-negative bacteria(1)(2)(3)(4). Two common 
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features of these models were the relatively long times required before infection of macrophages 
resulted in caspase-11 activation  (approximately 16 h) and that the majority of bacteria studied 
were extracellular non-pathogens, extracellular pathogens, or vacuolar pathogens. Considering 
our data indicating that caspase-11 responds within 2-4 h of infection with cytosol invasive 
bacteria together with the work of our lab(5) and Dr. Vishva Dixit’s(6) establishing cytosolic 
LPS as the ligand for caspase-11, it is reasonable to hypothesize that observations demonstrating 
caspase-11 activation after prolonged infection with vacuolar or extracellular bacteria reflect rare 
events of phagosomal rupture or translocation of phagosomal contents to the cytosol. That 
caspase-11 specifically responds to cytosolic bacteria is not trivial, as no survival benefit had 
ever been attributed to caspase-11 prior to the study detailed in Chapter 2(7) despite 
investigations of the role of caspase-11 in defense against vacuolar bacteria(2)(8). Nevertheless, 
our data do not rule out physiologically significant effects of caspase-11 responding to 
extracellular or vacuolar bacteria. Indeed, the well-established role of caspase-11 in the 
endotoxic shock model of sepsis may extend to genuine bacteremia resulting from infection with 
extracellular or vacuolar bacteria, where infrequent vacuolar lysis events may accumulate during 
prolonged bacteria exposure to caspase-11 expressing cells. Furthermore, caspase-11 contributes 
to limiting S. Typhimurium replication in the intestine, but not at systemic sites(9); limits 
microbiota mediated pathology resulting from DSS exposure(10)(11)(12); and perhaps protects 
against Citrobacter rodentium infection in Rip2-deficient mice(13). It is worth noting that 
intestinal epithelial cells may be prone to cytosolic invasion by normally vacuolar bacteria, as S. 
Typhimurium has been observed to escape to and replicate robustly in the cytosol of these 
cells(14); this tendency could explain the apparent importance of caspase-11 in mitigating 
colitogenic infections. 
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IFN signaling and caspase-11 
 Several studies demonstrate a requirement for STAT-1 signaling, initiated downstream of 
both type I and II IFN signaling, in caspase-11 activation in response to infection with vacuolar 
bacteria and certain bacteria that escape the vacuole(2)(3)(7). This requirement does not seem to 
extend to direct electroporation of LPS into the cytosol of cells(15) or certain LPS transfection 
conditions(6), suggesting that IFN signaling might enhance the availability of caspase-11 
activating ligand during infection. Indeed, Meunier and colleagues suggest that IFN induced 
GTP binding protein (GBP) expression is critical for caspase-11 activation in response to S. 
Typhimurium infection(16), where GBP2 in particular mediates lysis of Salmonella containing 
vacuoles(16). GBPs are highly upregulated in response to IFN and have been shown to restrict 
pathogen replication by enhancing the bactericidal activity of phagosomes(17). In a study from 
Dr. Joern Coer’s lab, in which our lab participated, Legionella pneumophila infection as well as 
L. pneumophila LPS transfection was shown to activate caspase-11 in IFN primed macrophages 
in a GBP chromosomal locus dependent manner(18). We did not observe any effect of GBPs on 
translocation of L. pneumophila to the cytosol, suggesting that GBP mediated bacterial lysis or 
modification of shed L. pneumophila LPS may be critical to its ability to activate caspase-11, a 
requirement not shared by LPS expressed by prototypical enteric bacteria such as E. coli(18).  
 
Coordination of caspase-11 with canonical inflammasome signaling 
 With a protective role for caspase-11 established, we can begin to examine how 
noncanonical inflammasome signaling via caspase-11 coordinates with canonical inflammasome 
signaling via caspase-1. Using B. thailandensis and B. pseudomallei infection as models in vivo, 
bacteria which activate both NLRC4 and caspase-11, it is clear that canonical and non-canonical 
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inflammasome pathways function non-redundantly: both Casp11- and Nlrc4-deficient mice are 
sensitive to high-dose infection, especially by aerosol, with B. thailandensis and B. 
pseudomallei(19)(7)(20). Work from our lab, in which I was not involved, suggests that 
canonical NLRC4 inflammasome signaling during B. thailandensis infection primes caspase-11 
via IL-18 and IFN-γ, and that this is required for a sufficiently rapid immune response capable of 
halting early bacterial replication during high dose B. thailandensis infection(20). This work 
suggests that certain cell types, such as resident peritoneal macrophages that are known to 
constitutively express NLRC4(21), function as sentinels that signal to rapidly expand expression 
of caspase-11 in other cell types – perhaps even in non-myeloid cells that B. thailandensis 
nevertheless infects. Although purely speculative, this hypothesis suggests that there is a fitness 
cost to constitutive expression of caspase-11 in mice, perhaps the result of endogenous caspase-
11 ligands being present, such as cholesterols or other lipids, which might drive smoldering 
baseline inflammation (discussed in the Chapter 3 discussion). 
 
Other caspase-11 functions in immunity 
 Prior to the pivotal 2011 study by Kayagaki and colleagues demonstrating that Casp1
–/–
 
mice carry an inactivating passenger mutation in Casp11, several groups suggested a role for 
caspase-11 in modulating actin dynamics. Work from Junying Yuan’s lab indicated a potential 
role for caspase-11 in regulating splenocyte cell migration in a manner independent of enzymatic 
activity by promoting Aip1-Cofilin-mediated actin depolymerization(22). Along these lines, 
Akhter and colleagues suggested that in mediating actin dynamics, caspase-11 enhances 
phagolysosomal fusion during infection by pathogenic bacteria(8). Follow up work suggested 
this is achieved by caspase-11, together with caspase-1, influencing Cofilin phosphorylation in a 
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caspase enzymatic activity dependent manner(23). Work from the Bevan lab suggests that T cell 
receptor signaling in CD8
+
 T cells is negatively regulated by caspase-11, an effect the authors 
hypothesize may be mediated by the effect of caspase-11 on actin dynamics(24).  
Whether the ability of caspase-11 to regulate actin is independent of the noncanonical 
inflammasome role of caspase-11 (i.e. its role as a cytosolic LPS sensor) was not explored in 
these studies, nor has interaction of these two distinct roles of capase-11 been investigated since. 
None of the aforementioned studies observed robust induction of caspase-11 dependent 
pyroptosis, suggesting either sub-lytic concentrations of LPS engage the ability of caspase-11 to 
regulate actin dynamics, or else additional, to be determined signals engage this activity. 
Furthermore, whether the pyroptotic activity of caspase-11 evolved before or after its ability to 
modulate actin dynamics is unknown, but is an interesting question nevertheless. 
 
CHAPTER 3 – CYTOPLASMIC LPS ACTIVATES CASPASE-11: IMPLICATIONS IN 
TLR-4 INDEPENDENT ENDOTOXIC SHOCK 
 
 The data presented in Chapter 3 established that cytosolic LPS activates caspase-11, that 
hypoacylated lipid A moieties fail to trigger caspase-11 activation, and that the priming of 
caspase-11 achieved by TLR4 in endotoxic shock can be bypassed with other PAMPs, such as 
TLR3 agonists. As noted, these results mirrored those of a similar study from Dr. Vishva Dixit’s 
lab(6), and have since been corroborated by a number of studies. In answering the question of 
what ligand activates caspase-11, our data raised a number of new questions (described in the 
“Future Directions and Caveats” below) while also intensifying the race to identify the ligand 
sensor. Shi and colleagues were the first to discover that caspase-11, as well as caspase-4 and -5, 
directly binds LPS, activating the enzyme(15). This manuscript and its implications for the field 
are explored below.  
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WildCARDs: Inflammatory caspases go it alone, directly detect LPS
7
 
The inflammatory caspases – among them caspase-1, murine caspase-11, and human 
caspase-4 and -5 (homologs of murine caspase-11) – are central to depriving infectious agents of 
intracellular replication niches. Upon responding to a given stimulus, they become catalytically 
active and initiate a form of programmed inflammatory cell death termed pyroptosis. Examining 
their homology and adjacent chromosomal arrangement in humans and other mammals, it is 
apparent that the inflammatory caspases originate from a series of gene duplications and 
subsequent divergences. 
A balanced caspase-1 response is critical to defense against a variety of infectious agents, 
whereas its aberrant activation underlies a number of immune pathologies. Less is known about 
caspase-11, -4, and -5 in infection; however, we have shown that one physiological role of 
caspase-11 is to detect and help clear cytosol invasive infections, such as those caused by 
Burkholderia thailandensis(25). More recent work has shown that caspase-11 mediates 
resistance to DSS-induced colitis(10) and clearance of Salmonella enterica serovar Typhimurium 
infected cells in the intestinal epithelium(9), perhaps limited to the times when these bacteria 
enter the cytosol. Likewise, caspase-4 responds to S. Typhimurium, enteropathogenic E. coli(9), 
and Shigella flexneri(26) infections in human intestinal epithelial cells. As with caspase-1, 
moderation of caspase-11 activity is key to limiting immune pathology: much of the lethality of 
bolus lipopolysaccharide (LPS) injection is mediated by caspase-11(27),(1),(6),(5). Shedding 
light on the mechanisms underlying these observations, our lab and that of Dr. Vishva Dixit 
independently determined that caspase-11 activates in response to cytosolic LPS(6),(5); whether 
caspase-4 (and/or -5) function similarly was not determined. 
                                                          
7
Hagar, J.A., Aachoui, Y., and Miao, E.A. WildCARDs: Inflammatory caspases directly detect 
LPS. Research Highlight. Cell Research, 25:149–150, 2014. 
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Of the inflammatory caspases, the activation mechanism of caspase-1 is the best 
described. Via its N-terminal CARD domain and an adaptor protein called ASC, caspase-1 
interacts with a family of cytosolic proteins – the inflammasomes – that detect signatures of 
infection (Figure 1). It then initiates pyroptosis and directs proinflammatory cytokine secretion. 
Inflammasomes thus follow the paradigm of apoptotic caspase activation, where apoptosis 
initiators caspase-2, -8 and -9 are recruited and activated by death domain family-containing 
upstream sensors: the piddosome, DISC, and apoptosome, respectively. Therefore, we and others 
assumed that the model of upstream sensor activating downstream caspase would hold for the 
other inflammatory caspases as well. For example, Kayagaki and colleagues coined the term 
‘noncanonical inflammasome pathway’ to describe activation of caspase-11 by a putative LPS 
sensor(1). However, a recent and elegant paper by Shi et al. proves this hypothesis wrong and, in 
doing so, describes an entirely novel paradigm of caspase activation(15). Moreover, the authors 
address many of the gaps in our understanding of caspase-11, -4, and -5 biology. 
Using electroporation to deliver bacterial components into the cytosol of cells, the 
authors first determined that caspase-4 responds to LPS in human monocytes by triggering 
pyroptosis. These findings extended to non-myeloid cells as well, where caspase-4 is 
constitutively expressed. The authors then demonstrated that caspase-4 and caspase-11 are 
functionally interchangable, supporting that they are homologs. 
Shi and colleagues next began identifying the molecule that actually binds LPS in the 
cytosol. They screened a number of NLRs and CARD domain containing proteins, but no 
candidates emerged. In agreement with this, unpublished work from our lab also ruled out 
virtually all known CARD-containing proteins as the LPS sensor. Clues to the identity of the 
sensor arose from the following astute observations: First, Shi et al. noticed that both caspase-4 
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and caspase-11, when purified from E. coli, eluted from columns as large oligomers, suggesting 
activation, whereas they eluted as monomers when expressed in and purified from insect cells. 
Second, they found that the LPS contents of E. coli purified caspase-4 and -11 were three orders 
of magnitude higher than what they typically observed when purifying bacterial proteins. 
Together, these results suggested that caspase-4 and -11 directly bind LPS. A series of pull-
downs and surface plasmon resonance experiments confirmed this notion, revealing stable 
interaction of LPS with caspase-4 and -11 in cells transfected with LPS. Furthermore, the authors 
showed that caspase-5 similarly binds LPS. In all cases, LPS binding and caspase 
oligomerization was CARD domain dependent; indeed, purified caspase-4 and -11 CARD 
domains were sufficient to bind LPS and oligomerize. Three regions of basic residues in the 
caspase-11 CARD domain – mostly conserved in caspase-4 and -5, but not caspase-1 – were 
critical for LPS binding. Last, the authors determined that caspase-11 and -4 oligomerization 
stimulates activation, as measured by cleavage of a fluorogenic substrate. Interestingly, the 
known antagonists of caspase-11 activation Lipid IVa and atypical LPS from Rhodobacter 
sphaeroides bound caspase-4 and -11, but failed to induce oligomerization and activation. 
The Shi et al. manuscript brings to light a number of fascinating perspectives. First, 
binding of LPS by caspase-4, -5, and -11 establishes a new paradigm for caspase activation: 
Direct detection of a cell death inducing ligand by a caspase. As the authors noted, this is 
analogous to horseshoe crab factors C/G, which bind LPS and β-(1,3)-D-glucan, respectively, 
and initiate coagulation cascades in haemolymphs.  
Second, the cell expression patterns of caspase-11, -4, and -5 may have important 
implications in future strategies for treating endotoxemia and Gram-negative sepsis. Caspase-11 
expression is inducible in myeloid cells, where its basal expression is low; in contrast, caspase-4 
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appears to be constitutively expressed in human myeloid cells. Therefore, aberrant translocation 
of LPS into the cytosol of human myeoloid cells may not require priming to activate caspase-4 
and initiate pyroptosis, perhaps sensitizing humans to the deleterious effects of LPS compared to 
mice. Investigating other cell type expression differences in this context will be informative. 
In answering so many questions about the biology of the inflammatory caspases, the 
work of Shi and colleagues raises many more. Among them: Why do antagonists of caspase-11 
fail to induce oligomerization? How do the CARD domains of these caspases “see” LPS? During 
binding of LPS by MD2, the acyl chains of lipid A extend into the binding cleft of MD2(28) in a 
manner sensitive to acyl chain length; in contrast, caspase-11 detects very diverse lipid A acyl 
chain lengths and structures, such as those of Salmonella and Legionella species(6),(5),(18), 
suggesting that the CARD domain may wrap around the lipid groups of LPS near the phosphate 
head groups of lipid A. Insight into these questions will surely come from crystal structures of 
caspase-11, -4, and -5 bound to various LPS structures. 
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Figure 5.1. Schematic of canonical and noncanonical inflammasome pathways to 
inflammatory caspase activation.  
Left: Inflammasomes such as AIM2, NLRP3, and NLRC4 detect contamination of the cytosol 
with microbial ligands (e.g. DNA, flagellin, bacterial type 3 secretion system components) or 
certain cellular perturbations. Via the adaptor protein ASC, they subsequently activate caspase-1, 
which initiates pyroptosis and secretion of the proinflammatory cytokines IL-1β and IL-18. 
Right: Caspase-4, -5, and -11 directly bind cytosolic LPS from Gram-negative bacteria. They 
subsequently oligomerize, activate, and initiate pyroptosis. 
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Future Directions and Caveats 
Many of the major open questions stemming from Chapter 3 and the work by Shi and 
colleagues(15) can be grouped into the following loose categories: Structural aspects of LPS and 
caspase-11/-4/-5 binding; evolutionary implications for Gram-negative bacteria; cell-type 
specific roles of caspase-11/-4/-5 in endotoxic shock and sepsis; and endogenous caspase-11/-4/-
5 ligands. 
 
Structural aspects of LPS and caspase-11/-4/-5 binding 
 Shi and colleagues established that LPS from prototypical enteric bacteria directly binds 
caspase-11, inducing its oligomerization and activation(15). Moreover, they determined that 
hypo-acylated LPS structures also physically bind caspase-11, but fail to induce oligomerization 
and activation. The exact stoichiometry of LPS and caspase-11 interaction remains to be 
determined. It is conceivable that multiple caspase-11 monomers bind a single lipid A moiety 
and that this becomes a functional catalytic unit. Hypo-acylated LPS structures could force a 
spatial conformation of lipid A and caspase-11 monomers incompatible with binding of 
sufficient additional caspase-11 monomers to achieve enzyme activation. Alternatively, 
LPS:caspase-11 heterodimer pairs could bind other pairs in such a way requiring hydrophobic 
interaction of free lipid A acyl chains – this being necessary for enzyme activation – which could 
be absent in tetra-acylated LPS. Solving the crystal structure of caspase-11 bound with various 
lipid A species will likely establish a model for caspase-11 activation by LPS. It will be 
interesting to determine how such a model compares to that of TLR4 activation, which involves 
transfer of LPS from CD14 to MD2, which then recruits and activates TLR4(28). Indeed, the 
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work of Shi and colleagues suggests that caspase-11 is alone sufficient to bind and activate in 
response to LPS(15). 
 
Evolutionary implications for Gram-negative bacteria 
 Caspase-11 and its human homologs surely exert evolutionary pressure on cytosol 
invasive bacterial pathogens and, possibly, vacuolar pathogens with high potential to 
contaminate the host cytosol (e.g. those that invade intestinal epithelial cells, discussed above). 
Such pressure likely synergizes with that exerted by TLR4, which has a similar affinity for hexa-
acylated LPS as caspase-11; however, pressure exerted by caspase-11 is likely also distinct from 
that exerted by TLR4, given differences in the lipid A structures to which these LPS sensors 
respond. For example, TLR4 responds weakly or not at all to penta-acylated LPS synthesized by 
bacteria such as B. thailandensis (29) or F. novicida lpxF (30), and not at all to tetra-acylated 
lipid A expressed by bacteria such as Yersinia pestis and wildtype F. novicida; in contrast, 
caspase-11 responds to penta-acylated lipid A from both B. thailandensis and F. novicida lpxF 
(30).  
Distinct from lipid A modifications that facilitate evasion of caspase-11, both Shigella 
species and Coxiella burnetii have recently been found to encode effectors that directly 
antagonize caspase-4 and caspase-11, respectively(26, 31). These data further highlighting the 
evolutionary pressure exerted by caspase-4/-11, and future studies may identify additional means 
by which bacteria antagonize caspase-11. 
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Cell-type specific roles of caspase-11/-4/-5 in endotoxic shock and sepsis  
 As noted, murine caspase-11 has a distinct expression profile compared to human 
caspase-4, with caspase-11 being expressed in intestinal epithelial cells(9) and myeloid cells 
after TLR and IFN stimulation, and caspase-4 seemingly constitutively expressed in most cell 
types(15). These differences have significant implications for how researchers translate animal 
model findings to human systems. For example, a critical unanswered question in murine models 
of endotoxic shock is what cell types take up and translocate LPS to the cytosol where it can 
interact with caspase-11; the answer is potentially far more complex in humans where the 
number of cell types expressing caspase-4 is more diverse. Along these lines, the signaling and 
physiological consequences of caspase-4 activation in many cell types may be far more complex 
than those of caspase-11 in only myeloid cells. 
 A related question that remains to be answered is how the physical state of LPS affects 
which cell types internalize and translocate it to the cytosol. For example, the tendency of and 
route by which an LPS micelle or monomer is to be internalized may be affected by the length, 
charge, and sugar modifications of the LPS O-antigen as well as whether it is decorated by 
complement or antibodies. These factors are well established to determine the acidification of an 
endosome and how much reactive oxygen is generated in response to its contents, which may 
affect vacuolar stability (e.g. by degree of membrane lipid peroxidation) and the tendency of LPS 
to translocate to the cytosol. Similarly, LPS as part of a bacterial outer membrane vesicle or part 
of cholesterol aggregates in the serum(32) is likely to be internalized by different cell types and 
experience very different fates than ultrapure LPS micelles or monomers. 
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Endogenous caspase-11/-4/-5 ligands 
 A final question that has potentially important clinical impact is whether endogenous 
ligands exist for caspase-11/-4/-5. Conceivably, certain phospholipids or cholesterol structures 
could bind and activate these caspases. In conditions such as high cholesterol or high fat diet, 
such an interaction could contribute to smoldering systemic inflammation thought to drive 
diseases such as type 2 diabetes. This effect may occur in conjunction with activation of caspase-
11/-4/-5 by elevated serum LPS that accompanies high fat diets(33) and HIV infection(34). 
 
CHAPTER 4 – LPS POTENTIATES INSULIN-DRIVEN HYPOGLYCEMIC SHOCK 
 The data in Chapter 4 detail our unexpected discovery that co-administration of LPS with 
insulin in poly(I:C) primed mice induces hypoglycemic shock. LPS impairs insulin clearance via 
activating caspase-11, TLR4, and complement, and this coincides with amplified insulin receptor 
signaling. Acting as an intermediary signaling molecule, PGE2 is a key mediator of the ability of 
LPS to potentiate insulin signaling. 
This work has the following potential clinical relevance: Critically ill patients routinely 
present with hyperglycemia(35). Conventional insulin therapy to bring blood glucose levels 
below 180 mg/dL has an established mortality benefit, but whether intensive insulin therapy to 
reestablish euglycemia confers a survival benefit remains hotly contested. This debate is 
complicated by the fact that septic patients stand out amongst the greater ICU population as 
being particularly prone to hypoglycemic episodes during intensive insulin therapy(36, 36), and 
incidence of severe hypoglycemia is a risk factor for death in the ICU(37, 37)(38, 38). Should 
our findings in a murine model of sepsis extend to human sepsis patients, they may inform 
development of insulin administration protocols, allowing safer study of intensive insulin 
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therapy, or allow for identification of patients least likely to experience extreme hypoglycemia 
during intensive insulin therapy and so are most likely to benefit. 
 Our data raise a number of questions, which fall into the following loose categories: 
Mechanism by which LPS impairs insulin clearance; cell-specific roles of TLR4 and caspase-11; 
and evolutionary significance of insulin resistance and impairment of insulin clearance resulting 
from inflammatory signaling. 
 
Mechanism by which LPS impairs insulin clearance 
 To determine the mechanism by which LPS impairs insulin clearance in vivo, future 
studies will need to address at least two questions: First, what cellular mechanisms for insulin 
clearance are perturbed by LPS induced inflammatory signaling in vivo, which is likely to be 
very different than in vitro because of cellular heterogeneity. Second, which tissue and cell types 
are most affected in vivo by LPS in their ability to clear insulin, and which insulin clearance 
pathways are most significantly impaired in these tissues. 
 Regarding tissue and cell types, the liver responds to and clears the majority of 
endogenous insulin on first pass, with the kidneys and, to a lesser extent, muscle clearing the 
majority of the remaining peripheral insulin(39). In our system, where insulin is injected 
intraperitoneally, all three tissue types likely contribute to insulin clearance. Given that poly(I:C) 
exposed mice develop mild hepatic inflammation and immune cell infiltration within hours(40), 
TLR4 and caspase-11 expression – and thus, LPS responsiveness – will perhaps be highest in the 
liver relative to other key insulin responsive tissues. This places insulin clearing hepatocytes in 
close proximity to locally acting signaling and reactive molecules induced by LPS. Thus, future 
studies should prioritize investigating whether the liver exhibits impaired insulin clearance, then 
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kidneys, muscle, and other tissues, further prioritized by whether data indicate priming induces 
immune infiltration and activation in them. Markers of insulin degradation pathway function, 
drawn from the discussion below, would serve to determine whether a given tissue is affected by 
LPS in its ability to clear insulin. As complementary studies, mice carrying floxed insulin 
receptor alleles could be crossed with tissue specific Cre expressing mice. Offspring would be 
challenged with insulin or LPS and insulin; serum insulin and glucose would be quantified, and 
disparate responses between mice of a given genotype treated with insulin or insulin and LPS 
would strongly suggest tissue specific effects of LPS signaling. These experiments are not 
without caveats, however, as such mice could have severe basal metabolic dysregulation. 
 There are several, non-mutually exclusive mechanisms by which LPS could impair 
insulin clearance at a cellular level. Insulin is primarily cleared via binding the insulin receptor, 
where it is subsequently internalized, dissociates from the receptor after endosome acidification, 
and undergoes degradation in a multistep pathway mediated by insulin degrading enzyme (IDE); 
the insulin receptor is subsequently recycled to the plasma membrane, only rarely together with 
intact insulin(39). LPS induced signaling molecules could impede this pathway at several steps. 
For example, receptor internalization could be limited, prolonging both its signaling half-life and 
its ability to bind additional serum insulin after normal recycling to the plasma membrane; 
endosomal maturation could be impaired, possibly prolonging signaling from the receptor, and 
preventing incorporation of insulin degrading enzymes and thus increasing the amount of insulin 
that co-recycles to the plasma membrane with the insulin receptor; and the degradative capacity 
of IDE and other enzymes involved in insulin breakdown could be inhibited, again increasing the 
amount of insulin that co-recycles to the plasma membrane with its receptor. Indeed, two studies 
have demonstrated that IDE is readily modified by reactive oxygen and reactive nitrogen species, 
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which impair its insulin degrading activity (41)(42), and pharmacological inhibition of IDE 
enhances insulin sensitivity and impairs insulin clearance in mice (43). Preliminary data from our 
lab suggests that the ability of liver lysates from LPS treated mice have a reduced ability to 
degrade exogenous insulin in vitro (data not shown), which supports the candidacy of LPS 
induced IDE impairment as a potential contributor the ability of LPS to potentiate insulin shock. 
Future studies will need to investigate this possibility in live cells where the normal insulin 
degradation pathway is intact. 
 Insulin clearance pathways that are independent of the insulin receptor exist(39). Their 
significance is unclear, as are the mechanisms by which they proceed; however, their activity 
increases with increasing serum insulin concentrations(39). Therefore, if insulin receptor -
independent pathways are critical to clearing insulin in primed mice, impairment of these by LPS 
could contribute to the extreme hypoglycemia of LPS and insulin challenged mice by enhancing 
the likelihood that serum insulin binds, for example, insulin receptor on skeletal muscle. 
 
Cell-specific roles of caspase-11 and TLR4 
 Stromal cells of insulin clearing tissues, such as hepatocytes and skeletal muscle cells, 
express TLR4(44)(45); it remains to be determined whether they can also express Casp11 after 
poly(I:C) priming. Moreover, as mentioned, poly(I:C) induces mild hepatic immune 
infiltration(40), and it is clear that peritoneal injection of even just DPBS induces immune 
infiltration to the peritoneal cavity (personal correspondence with Dr. Ine Jorgensen). Therefore, 
LPS could act directly on cells most responsible for clearing insulin, inducing, for example, 
reactive oxygen species via TLR4. Alternatively, LPS could act indirectly via TLR4 and 
caspase-11 on immune cells, inducing expression of signaling molecules that then act on the 
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cells responsible for clearing insulin. Given the relative importance of caspase-11 in LPS 
amplifying immune signaling, an attractive direction would be to obtain floxed Casp11 mice and 
cross with mice expressing Cre from tissue specific promoters, such as alb for hepatocytes or 
lysM for myeoloid cells. Such studies would complement mRNA and protein expression analysis 
of caspase-11 in various cells in vivo. 
 Elucidating cell-specific roles of caspase-11 and TLR4 will allow subsequent exploration 
of cell-specific roles of downstream signaling molecules. For example, the primary source of 
PGE2 and the upstream LPS sensors most important for its generation remain to be determined. 
Similarly, should reactive oxygen and nitrogen species be implicated in impairing insulin 
clearance, discovering their sources – both cell type and whether they are phagocyte oxidase or 
mitochondrial derived – will become important questions. 
 As previously discussed, identifying the cell types responsible for caspase-11 dependent 
effects on insulin clearance paves the way for exploring the mechanism by which cells 
translocate LPS to the cytosol, which has far reaching implications in sepsis research. 
 
Evolutionary significance of insulin resistance and impairment of insulin clearance resulting 
from inflammatory signaling 
 Tangential to the clinical significance of our work, but interesting questions nevertheless, 
are the evolutionary significance of insulin resistance induced by inflammatory signaling – such 
as occurs in type 2 diabetes and sepsis – and, now, the significance of impaired insulin clearance. 
During severe infection, rapid proliferation and activation of immune cells is critical to 
containing pathogen growth and spread, and such immune amplification requires high rates of 
glycolysis(46). Thus, insulin resistance in tissues such as skeletal muscle may serve to limit their 
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glucose utilization, saving blood glucose for immune cells. This may have been particularly 
important during severe infection before modern medicine, where nutritional intake would be 
limited. Integrating our observations in Chapter 4, impairing insulin clearance may allow more 
endogenous insulin to pass through the liver to peripheral sites of infection, where insulin may be 
critical to modulating immune function. 
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